Compounds for coating nanostructures

By using specific compounds and hydrosilylation reactions in nanostructure coatings, impurity problems and complexity of purification steps are solved, and the preparation of high-purity compounds and stable nanostructures is achieved, reducing production costs and improving drug quality .

CN118922471APending Publication Date: 2024-11-08SPAGO NANOMEDICAL
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202380026527.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-08
Filing Date
2023-03-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art has impurity problems when preparing nanostructured coatings, resulting in increased production costs and affected drug product quality, and the purification steps are complex.

Method used

Specific compounds are used to introduce silane groups through hydrosilylation reactions according to compounds of formula (I) and formula (II), and efficient purification methods are used to avoid additional purification steps, improving the purity of the compound and the stability of the nanostructure.

Benefits of technology

The preparation of high-purity compounds is achieved, reducing production costs, improving the stability and biocompatibility of nanostructures, and simplifying the purification process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118922471A_ABST
    Figure CN118922471A_ABST
Patent Text Reader

Abstract

The present application relates to a compound according to formula (I) and to a process for preparing the compound and to the use of the compound as an intermediate in the preparation of coated nanostructures. The invention also relates to the nanostructure, the use of the nanostructure as a radionuclide carrier, and a pharmaceutical composition comprising the nanostructure.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to compounds suitable for coating polymer nanostructures, which serve as intermediates in the preparation of nanostructures for use in systemic radiation therapy and imaging. Background Art

[0002] Polymer coatings, such as those containing PEG, can be used to prevent aggregation of nanostructures and improve the biocompatibility of nanostructures. Although PEG remains the polymer of choice, other polymers suitable for coating nanostructures for biomedical applications have been described, such as polyvinylpyrrolidone and polyamides.

[0003] WO2018130713 describes a dipodal structure with one or more short PEG chains. The structure has a cyclic core, such as an aromatic core, which has been shown to produce some impurities during large-scale production.

[0004] This problem is described in detail in WO2021122859, and a method for removing impurities is proposed. However, this method includes several purification steps, which increases production costs and may also affect the quality of the final drug product including the coated nanostructures.

[0005] The purpose of the present application is to overcome these problems. Summary of the invention

[0006] According to a first aspect, the above-mentioned objects and other objects are fully or at least partially achieved by the compounds defined in claim 1. According to this claim, the above-mentioned objects are achieved by compounds according to formula (I):

[0007]

[0008] Poly 1 and Poly 2 independently selected from the group consisting of hydrogen and a hydrophilic polymer group with a molecular weight of 400Da to 10000Da; wherein Poly 1 or Poly 2 At least one of the Y is a hydrophilic polymer group having a molecular weight of 400Da to 10000Da. 1 and Y 2 is independently -A(CH2) n B-; wherein A is bound to X; Y 1 B in the binds to Poly 1 ; Y 2 B in the binds to Poly 2; n is an integer between 0 and 5; A is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond; and B is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond, provided that when Poly 1 or Poly 2 Zhong and Y 1 or Y 2 When the bonded atom is not a carbon atom, B is a covalent bond. 3 and Y 4 is independently -E(CH2) m -; wherein E is bound to X; m is an integer between 2 and 5; and E is independently selected from the group consisting of -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond. X is selected from the group consisting of the structure X 1 , X 2 , X 3 , X 4 and X 5 The group composed of

[0009]

[0010] The bold bonds represent bonds to Y 1 or Y 2 non-bold bonds are those bonded to Y 3 or Y 4 and p is an integer between 1 and 5. 1 and Z 2 Independently -SiR 1 R 2 R 3 , where R 1 , R 2 and R 3 Independently selected from the group consisting of chlorine, bromine, iodine, lower alkoxy, aryloxy, carboxyl, amino and -NH-acyl.

[0011] These compounds (also called coating precursors) can be applied in a layer on the surface of the nanostructure to extend the circulation time of the nanostructure in the blood (plasma half-life) and allow sufficient time to bind to cells in the target tissue. In addition, the coated nanostructure has a prolonged stability.

[0012] Such compounds have the advantage that, after synthesis of the compound, no additional purification steps are required, which is beneficial to the cost and quality of the pharmaceutical product comprising the nanostructures coated with the coating precursor.

[0013] Poly 1 and Poly 2 May include ethylene glycol units. Alternatively, Poly 1 and Poly 2 Other hydrophilic polymers may be included, such as polyvinyl pyrrolidone and polyamides. Such polymers, while more chemically sensitive than polyethylene glycol, such as to hydrolysis, may be used in some cases because these groups are generally less immunogenic than polyethylene glycol.

[0014] Poly 1 and Poly 2 It can contain 10 to 200 ethylene glycol units. Several ethylene glycol units linked together are also called polyethylene glycol chains or PEG chains. 1 and Poly 2 The polyol may comprise 12 to 170, such as 15 to 120, such as 20 to 90, such as 30 to 75, such as 35 to 60, such as 40 to 50, such as 42 to 48, such as 45 ethylene glycol units. 1 and Poly 2 It may contain 12 to 30 ethylene glycol units. 1 and Poly 2 The polyol may comprise 15 to 60, such as 20 to 50, such as 30 to 60 ethylene glycol units. 1 and Poly 2 40 to 100, such as 50 to 90, such as 60 to 120, such as 75 to 170 ethylene glycol units may be included.

[0015] Preferably, Poly 1 and Poly 2 It comprises 30 to 60 ethylene glycol units, even more preferably 40 to 50 ethylene glycol units.

[0016] Optionally, Poly 1 and Poly 2 In particular, when ethylene glycol units are included, they may be capped with end groups, such as lower alkyl groups. 1 and Poly 2 It comprises 30 to 60 ethylene glycol units, such as 40 to 50 ethylene glycol units, and is terminated by a capping group, wherein the capping group is a methyl group or an ethyl group.

[0017] According to one embodiment, Poly 1 and Poly 2 It is a hydrophilic polymer group with a molecular weight of 400Da to 10000Da.

[0018] According to another embodiment, n is an integer between 1 and 3, preferably n is 1 or 2, even more preferably n is 1. Such compounds are stable and can be obtained synthetically in a convenient manner.

[0019] According to a further embodiment, in Y 1 and Y 2 In this case, n is 1. Such compounds are stable and can be obtained synthetically in a convenient manner.

[0020] According to another embodiment, wherein X is X 1 .

[0021] According to one embodiment, in Y 1 and Y 2 In which A is a covalent bond, B is -O-, and n is an integer between 1 and 3. Such compounds are stable and can be obtained synthetically in a convenient manner.

[0022] According to another embodiment, in Y 3 and Y 4 In this case, E is a covalent bond. Such compounds are stable and can be synthesized in a convenient manner.

[0023] According to a further embodiment, the hydrophilic polymer group comprises a PEG chain. Optionally, the PEG chain is terminated with a lower alkyl group.

[0024] According to another embodiment, each hydrophilic polymer group comprises 20 to 150 ethylene glycol residues, preferably 30 to 60, for example 40 to 50 ethylene glycol groups. Such compounds are resistant to interaction with plasma proteins, have a long plasma half-life, and can be obtained synthetically in a convenient manner.

[0025] According to a further embodiment, Poly 1 and Poly 2 It is ω-methyl-(ethyleneoxy) w , where w is 20 to 150; 1 and Y 2 In which A is a covalent bond, B is -O-, and n is 1; Y 3 and Y 4 are -CH2-CH2-CH2-; X is X 1 ; and Z 1 and Z 2 Independently selected from the group consisting of triethoxysilyl and trimethoxysilyl. Such compounds can be synthesized in a convenient manner, have convenient reactivity when used as a coating, and produce coated nanostructures with good in vivo performance. Preferably, w is 30 to 60, and even more preferably w is 40 to 50.

[0026] A second aspect of the present application relates to compounds according to formula (II):

[0027]

[0028] Where R 7 and R 8 independently selected from the group consisting of lower alkyl; p is an integer between 20 and 150; q is an integer between 20 and 150; r is an integer between 1 and 3; s is an integer between 1 and 3; t is an integer between 0 and 3; and u is an integer between 0 and 3. In formula (II), X is selected from X 1 , X 2 , X 3 , X 4 and X 5 The groups consist of:

[0029]

[0030] The bold bonds represent bonds to [CH2] r and [CH2] s bonds to [CH2] t and [CH2] u and p is an integer between 1 and 5.

[0031] Preferably, p is an integer between 30 and 60, such as between 40 and 50.

[0032] Preferably, q is an integer between 30 and 60, such as between 40 and 50.

[0033] Preferably, lower alkyl is methyl and / or ethyl.

[0034] In a third aspect, the present application relates to the use of a compound according to formula (II) as defined above for the preparation of a compound according to formula (I) as defined above, wherein the hydrophilic polymer group in formula (I) comprises a PEG chain.

[0035] In a fourth aspect, the present application relates to a method for purifying a compound according to formula (II) as defined above, comprising the following steps:

[0036] a) providing an aqueous solution of an impure compound according to formula (II) as defined above, wherein the aqueous solution comprises:

[0037] water in an amount of 7.5 to 16.5 times the total mass of the impure compounds according to formula (II) as defined above; and

[0038] NaCl in an amount of 6% to 9% (w / v) based on the amount of water;

[0039] b) subjecting the aqueous solution of step a) to between 2 and 5 intermediate extractions at a temperature between 40° C. and 70° C., wherein each intermediate extraction comprises the following steps:

[0040] b1) optionally; adding an additional portion of NaCl such that the total amount of NaCl added corresponds to an amount of NaCl less than 9% (w / v) of the amount of water in the aqueous solution of step a);

[0041] b2) extracting the aqueous solution with a carboxylate solvent; and

[0042] b3) removing the organic phase to provide an aqueous phase;

[0043] c) adding to the aqueous phase from step b3) an amount of NaCl in an amount of at least 1% of the amount of water in step a), such that the total amount of NaCl corresponds to an amount of NaCl between 8% and 12%, and subjecting the aqueous phase to 2 to 5 product extractions at a temperature between 40° C. and 70° C., wherein each product extraction comprises the following steps:

[0044] c1) extracting the aqueous phase with a carboxylic acid ester solvent; and

[0045] c2) removing the organic phase;

[0046] d) combining the organic phases from each step c2);

[0047] e) concentrating the combined organic phases from step d) to obtain a residue;

[0048] f) dissolving the residue from step e) in an aqueous buffer having a pH between 6 and 9 to provide an aqueous phase;

[0049] g) subjecting the aqueous phase from step f) to 2 to 4 polishing extractions, wherein each polishing extraction comprises the following steps:

[0050] g1) extracting the aqueous phase from step f) with a chlorinated solvent; and

[0051] g2) removing the organic phase;

[0052] h) combining the organic phases from each step g2); and

[0053] i) concentrating the combined organic phases from step h) so as to obtain a residue comprising a diPEGylated diene according to formula (II) as defined above having an impurity content of less than 10% (w / w).

[0054] Compounds according to formula (II) as defined above and purified according to the methods described herein can be used to produce compounds according to formula (I) with high purity. Thus, no additional purification steps are required, which is beneficial to the cost and quality of the produced coating precursors and nanostructures coated with the coating precursors.

[0055] The amount of impurities as described above can be measured by HPLC ELSD.

[0056] The temperature of step b) may be between 50 and 70° C., preferably between 55 and 65° C., for example 60° C. It has been shown that at these temperatures, emulsions formed at lower temperatures break up and allow complete separation of the phases.

[0057] In step c1), the carboxylic acid ester may be ethyl acetate or isopropyl acetate. Such carboxylic acid esters are good solvents for the substance to be extracted and their boiling points allow working at the desired temperature while still being removable by evaporation.

[0058] After step d), the organic phase can be subjected to a drying step (step e) before concentration. This can be achieved by many methods known to those skilled in the art, for example by drying over a desiccant such as magnesium sulfate or using molecular sieves. The drying step is desirable because subsequent steps in the synthesis generally require anhydrous conditions.

[0059] Preferably, the aqueous buffer in step f) is aqueous sodium bicarbonate, as it achieves the desired pH value in a convenient and economical manner.

[0060] In step g1), the chlorinated solvent may be dichloromethane, chloroform or tetrachloroethane. Such chlorinated solvents are preferred because they have a high affinity for the PEGylated species.

[0061] Preferably, the chlorinated solvent is dichloromethane.

[0062] In a fourth aspect, the present application relates to a method for preparing a compound according to formula (I) as defined above, wherein Poly 1 and Poly 2 The method comprises the following steps:

[0063] i) providing a diene according to formula (II) as defined above, optionally purified as described above;

[0064] ii) reacting a diene with at least 30 equivalents of the structure HSiR in the presence of a platinum catalyst and an aromatic solvent at a temperature between 10°C and 35°C 1 R 2 R 3 contacting with a hydrosilylation agent, wherein R 1 , R2 and R 3 independently selected from the group consisting of lower alkoxy;

[0065] iii) removing excess hydrosilylation agent; and

[0066] iv) Removal of platinum from the product.

[0067] Thus, this method can be used to synthesize silylated bipodal structures comprising one or more poly(ethylene glycol) methyl ether chains.

[0068] Importantly, no additional purification steps are required, which benefits the cost and quality of the resulting coating precursors and nanostructures coated with the coating precursors.

[0069] In step ii), the alkoxy groups are preferably methoxy and / or ethoxy groups. Such compounds have suitable reactivity when used to coat nanostructures while still being sufficiently stable to allow easy handling.

[0070] Preferably, the alkoxy group in step ii) is methoxy and / or ethoxy.

[0071] Preferably, after step ii), step iii) is carried out after a period of time after which the reaction has proceeded substantially to completion, for example after 24 hours.

[0072] In a fifth aspect, the present application relates to the use of a compound according to formula (I) as described above or a compound according to formula (II) as described above or a product of any of the methods as described above as an intermediate in the preparation of a coated nanostructure. Preferably, the compound used comprises 30 to 60, such as 50 to 50 ethylene glycol groups.

[0073] In a sixth aspect, the present application relates to spherical nanostructures having a hydrodynamic diameter between 10 nm and 100 nm, wherein the nanostructures have a coating derived from a compound according to formula (I) as described above or a compound according to formula (II) as described above or a product of any of the above methods. The hydrodynamic diameter is measured as the average of the volume-weighted peaks of a sample measured by DLS at 25°C in an aqueous solution (also referred to as saline) with an ionic strength corresponding to 150 mM NaCl or in saline with 8% ethylene glycol (v / v) (as described below).

[0074] Such nanostructures could be used for cancer treatment and imaging.

[0075] The hydrodynamic diameter may be between 10 nm and 100 nm, such as between 12 nm and 80 nm, such as between 14 nm and 60 nm, such as between 16 nm and 50 nm, such as between 18 nm and 45 nm, such as between 20 nm and 40 nm, such as between 25 nm and 35 nm.

[0076] The nanostructure may include a chelating group. The chelating group may be a bisphosphonate, preferably a geminal bisphosphonate.

[0077] According to one embodiment, the spherical nanostructures further comprise a radionuclide. The radionuclide may be suitable for medical imaging, such as a radionuclide suitable for PET or a radionuclide suitable for SPECT, and / or a radionuclide suitable for radionuclide therapy.

[0078] Radionuclides can be 177 Lu, 153 Sm and / or 90 Y.

[0079] In a seventh aspect, the present application relates to a pharmaceutical composition comprising a plurality of spherical nanostructures as described above. The nanostructures may include radionuclides. Therefore, the pharmaceutical composition may include "empty" nanostructures (i.e., nanostructures that do not carry radionuclides) and / or "loaded" nanostructures (i.e., nanostructures that carry radionuclides).

[0080] In an eighth aspect, the present application relates to a pharmaceutical composition for use in cancer treatment or in imaging, wherein the pharmaceutical composition comprises a plurality of spherical nanostructures comprising a radionuclide. The radionuclide may be suitable for medical imaging, such as a radionuclide suitable for PET or a radionuclide suitable for SPECT, and / or a radionuclide suitable for radionuclide therapy.

[0081] In a ninth aspect, the present application relates to the use of the spherical nanostructure of the present application as a carrier of a radionuclide. The radionuclide may be suitable for medical imaging, such as a radionuclide suitable for PET or a radionuclide suitable for SPECT, and / or a radionuclide suitable for radionuclide therapy. Specifically, the radionuclide may be 177 Lu, 153 Sm and / or 90 Y.

[0082] Other objects, features and advantages of the present application will emerge from the following detailed description, experimental data and the appended claims.It should be noted that the present application relates to all possible combinations of features.

[0083] In general, unless otherwise expressly defined herein, all terms used in the claims are to be interpreted according to their ordinary meaning in the technical field. Unless otherwise expressly stated, all references to "a / an / the [component, device, step, etc.]" should be openly interpreted as referring to at least one example of the component, device, step, etc. The steps of any method disclosed herein do not have to be performed in the exact order disclosed unless expressly stated.

[0084] As used herein, the term "comprises" and variations of this term are not intended to exclude other additives, components, integers or steps.

[0085] Definition of terms

[0086] As used herein, a chemical bond that ends with a curved line perpendicular to the chemical bond indicates that the bond connects the structure shown to some portion of the structure of a chemical entity that is not shown in the structure. For example,

[0087]

[0088] indicates that R is bound to some part of the structure of the chemical entity not shown in the structure.

[0089] The term "nanostructure" as used herein relates to entities having overall dimensions in the nanometer range, ie up to 100 nm.

[0090] As used herein, the term "spherical" is intended to describe a shape in which the minor axis is not less than half the major axis, i.e., the length of the longest axis through the center (center of gravity) of the structure is no more than twice the length of the shortest axis through the same point. For purposes of illustration, and not limitation, see Figure 1 .

[0091] The term "spherical nanostructure" as used herein relates to a nanostructure having a generally spherical form or shape as described above. This means that shapes such as sheets, rods, tubes, toroids, chains and ribbons are not included.

[0092] The term "monomer" as used herein is a molecule that can homovalently bind to other molecules of the same type (and optionally, other types) to form a polymer, wherein the polymer is a macromolecule composed of several monomer residues.

[0093] As used herein, the term "monomer residue" refers to atoms derived from one monomer unit that is incorporated into a larger polymer. Depending on how the monomers are linked, all atoms may be retained, or some atoms may be lost when bonds are formed.

[0094] As used herein, the term "polymer group" refers to the polymer portion of a chemical structure, i.e., a group comprising multiple monomer residues. The monomer residues may be identical or different. The polymer group may be linear or branched. The end of a polymer group may include a structure different from the remainder of the polymer group. Typically, it is clear to those skilled in the art how the polymer group is bonded to the remainder of a chemical structure (part of which is formed by the polymer group). For some polymer groups that have the ability to form a key with the remainder of a chemical structure (part of which is formed by the polymer group) in various ways, it may be necessary to indicate how the polymer group is bonded to the remainder of the chemical structure.

[0095] As used herein, the term "hydrophilic polymer" refers to a polymer or polymer group having repeating monomer units in a ratio ((oxygen + nitrogen) / total number of non-hydrogen atoms) greater than or equal to 0.25.

[0096] As used herein, the term "PEG" refers to the polymer polyethylene glycol, represented by the following structure:

[0097]

[0098] or any polymer or polymer group comprising a polyethylene glycol residue, described by the following structure:

[0099]

[0100] As used herein, the term "mPEG" refers to the polymer polyethylene glycol methyl ether represented by the following structure:

[0101]

[0102] or a polymer group having the structure

[0103]

[0104] As used herein, the terms "covalently attached," "covalently linked," and "covalently bound" are synonymous and their meanings are well known to those skilled in the art.

[0105] As used herein, the term "independently selected from" means that each of the different ingredients mentioned before the term is selected from the group following the term independently and separately from the selection of the other mentioned ingredients.

[0106] The term "geminal bisphosphonate group" refers to two phosphonate groups separated by one carbon atom, i.e., the two phosphonate groups are bound to the same carbon atom. Compounds comprising such geminal bisphosphonate groups are generally referred to as 1,1-bisphosphonates (or 1,1-diphosphonates). The phosphonate groups in the geminal bisphosphonate group may be substituted.

[0107] As used herein, the term "alkyl" refers to a substituted or unsubstituted, fully saturated (no double or triple bonds) straight or branched hydrocarbon group. In this article, the alkyl group can have 1-10 carbon atoms. Typical alkyl groups include, but are not limited to, methyl, ethyl, propyl, butyl, pentyl, hexyl, etc.

[0108] The term "lower alkyl" as used herein refers to an alkyl group having 1 to 8 carbon atoms.

[0109] As used herein, the term "alkoxy" refers to the formula -OR, wherein R is a lower alkyl group, such as methoxy, ethoxy, n-propoxy, 1-methylethoxy (isopropoxy), n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, amyloxy, isopentyloxy, etc. The alkoxy groups of the present application may be optionally substituted.

[0110] As used herein, the term "aryl" refers to a carbocyclic ring (i.e., all carbon) or two or more fused rings (i.e., rings sharing two adjacent carbon atoms) with a completely delocalized π electron system. Examples of aryl include, but are not limited to, benzene, naphthalene and azulene. Aryl according to the application can be optionally substituted, such as phenoxy, naphthoxy, azuleneoxy, anthraceneoxy, naphthylthio, phenylthio, etc. Aryloxy can be optionally substituted.

[0111] As used herein, the term "acyl" refers to the functional group RC(=O)-, where R is an organic residue.

[0112] As used herein, the terms "siloxane bond," "siloxane connection," and "siloxane network" refer to a moiety including Si-O-Si.

[0113] As used herein, the term "coating" refers to a layer of material applied to a surface to impart one or more properties to the surface. Typically, the coating is covalently attached to the surface. Typically, the surface is a nanostructured surface. Typically, the properties imparted to the surface include inertness, such as biological inertness. The term "coating" may also refer to the process of applying a coating to a surface, and the term "coat" may be used as a verb, meaning "to apply a coating." It is generally clear to a person skilled in the art which form of the word "coating" is being used at a particular moment.

[0114] The term "coated nanostructure" (or nanostructure with a coating) is used to describe a material that can be produced from the nanostructure of the present application by adding one or more layers of additional materials. Typically, such nanostructures with coatings are intended for use in radioisotope therapy.

[0115] The term "chelating group" refers to a chemical group that can successfully compete with water in the electrostatic binding to a positively charged ion. The binding of a single chelating group is not very strong, but if several chelating groups surround a positively charged ion, a synergistic increase in binding occurs. This is called chelation.

[0116] As used herein, the term "organosilane" refers to an organic compound containing one or more carbon-silicon bonds.

[0117] The term "alkoxysilane" as used herein refers to an organic group having the formula Si-OR bonded to silicon via an oxygen atom, wherein R is a lower alkyl group, such as methoxy, ethoxy, n-propoxy, 1-methylethoxy (isopropoxy), n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentoxy, isopentoxy, and the like.

[0118] The term "hydrodynamic diameter" as used herein refers to the diameter of a hypothetical hard sphere that diffuses at the same speed as the nanostructure in a solution, i.e., the diameter of an equivalent hard sphere calculated by the diffusion coefficient according to the Stokes-Einsteins Equation. The term is also referred to as "Stokes diameter" or "Stokes-Einstein diameter". The behavior of the sphere includes hydration and shape. The diffusion coefficient is in turn calculated from time-dependent light scattering data obtained, for example, by dynamic light scattering (DLS) technology. Other technical methods for measuring the diffusion coefficient of nanostructures are known to those skilled in the art and can be used alternatively. In these cases, the measurement requires reference to the DLS measurement. As a comparison, bovine serum albumin in aqueous saline (150mM NaCl) was measured by DLS at pH = 7 and room temperature to have a hydrodynamic diameter of 6.9nm. Depending on whether the number average, volume average, or scattering intensity average is used, the calculated values ​​may be slightly different. The volume average is usually the most useful because it shows which nanostructure size most of the material has. The average diameter referred to herein refers to the volume average measured at 25°C in aqueous saline or in 8% ethylene glycol (v / v) in saline.

[0119] The term "DLS" as used herein is an abbreviation for Dynamic Light Scattering (a particle size determination method), and may also be referred to as Photon Correlation Spectroscopy or Quasi-elastic Light Scattering. If not otherwise specified, a given DLS size as described herein and in the claims refers to the average value of the volume-weighted peaks of the sample measured by DLS at 25°C in an aqueous solution (also referred to as saline) with an ionic strength corresponding to 150 mM NaCl or in saline with 8% ethylene glycol (v / v). The hydrodynamic diameter specified herein is the average value of the volume-weighted peaks of the sample measured by DLS at 25°C in an aqueous solution (also referred to as saline) with an ionic strength corresponding to 150 mM NaCl or in saline with 8% ethylene glycol (v / v).

[0120] Unless otherwise stated, impurities in the products of any process described herein are given as impurities measured by HPLC ELSD.

[0121] As used herein, the term "HPLC ELSD" is an acronym for High Pressure Liquid Chromatography Evaporative Light Scattering Detector.

[0122] As used herein, SEC-ELSD is an acronym for Size Exclusion Chromatography with Evaporative Light Scattering Detection.

[0123] As used herein, the term "ICP-OES" is an acronym for Inductively Coupled Plasma Optical Emission Spectroscopy. ICP-OES is a technique used to determine the elemental composition of a sample.

[0124] As used herein, the term "molecular weight" refers to the molecular weight of a compound with a specific molecular structure, or the weight average molecular weight (also referred to as mass average molar mass or weight average molar mass) of a compound including a polymer portion, wherein the number of monomers in the polymer portion varies between different single molecules. Therefore, the molecular weight of a compound with a specific molecular structure is a molecular weight calculated based on the number and type of atoms of the compound or measured by, for example, mass spectrometry. The molecular weight of a compound including a polymer portion refers to a weight average molecular weight, also referred to as a mass average molar mass or a weight average molar mass, which can be measured by, for example, gel filtration or size exclusion chromatography (SEC). More specifically, the weight average molecular weight can be measured according to ISO 16014-1:2019 and ISO 16014-5:2019 ("average molecular weight and molecular weight distribution of polymers determined using size exclusion chromatography"), or can be measured according to ISO 16014-1:2019 in combination with any one of ISO 16014-2:2019 to ISO16014-4:2019. Alternatively, the weight average molecular weight can be determined by SEC and confirmed using liquid chromatography-mass spectrometry (LC-MS) or high performance liquid chromatography (HPLC).

[0125] As used herein, the term "bioinert" refers to materials that are biocompatible, ie, non-toxic to mammals and mammalian cells, while being stable to in vivo degradation, persisting in the human body (less than 10% degradation) for a week or more.

[0126] The term "radionuclide" refers to an unstable form of a chemical element that undergoes radioactive decay, emitting alpha, beta and / or gamma radiation.

[0127] As used herein, the expression "radionuclide for imaging and / or radiotherapy" refers to actinium-225 ( 225 Ac), copper-62( 62 Cu), copper-64( 64 Cu), copper-67( 67 Cu), Gallium-67( 67 Ga), gallium-68( 68 Ga), holmium-166( 166 Ho), indium-111( 111 In), lead-212( 212 Pb), Lutetium-177( 177 Lu), radium-223 ( 223 Ra), rhenium-186 ( 186 Re), rhenium-188 ( 188 Re), Rubidium-82( 82 Rb), Samarium-153 ( 153 Sm), Strontium-89 ( 89Sr), Technetium-99m( 99m Tc 3+ )、Thallium-201( 201 Tl), Thorium-227 ( 227 Th), Yttrium-86( 86 Y), Yttrium-90 ( 90 Y), and zirconium-89 ( 89 The expression "radionuclide for imaging and / or radiotherapy" also covers combinations of two or more of the abovementioned radionuclides.

[0128] As used herein, the expression "radionuclide for imaging" refers to copper-62( 62 Cu), copper-67( 67 Cu), Gallium-67( 67 Ga), gallium-68( 68 Ga), indium-111( 111 In), Lutetium-177( 177 Lu), rhenium-186 ( 186 Re), Rubidium-82( 82 Rb): Technetium-99m( 99m Tc 3+ )、Thallium-201( 201 Tl), yttrium-86 ( 86 Y) and zirconium-89 ( 89 The expression "radionuclide used for imaging" also covers combinations of two or more of the abovementioned radionuclides.

[0129] As used herein, the expression "radionuclide for PET imaging" refers to copper-62( 62 Cu), Gallium-68( 68 Ga), Rubidium-82( 82 Rb), yttrium-86 ( 86 Y) and zirconium-89 ( 89 The expression "radionuclide for PET imaging" also covers combinations of two or more of the abovementioned radionuclides.

[0130] As used herein, the expression "radionuclide for SPECT imaging" refers to gallium-67 ( 67 Ga), indium-111( 111 In), Technetium-99m( 99m Tc 3+ )、Lutetium-177( 177 Lu) and thallium-201( 201 T1). The expression "radionuclide for SPECT imaging" also covers combinations of two or more of the abovementioned radionuclides.

[0131] As used herein, the expression "radionuclide for use in radiation therapy" refers to actinium-225 ( 225 Ac), copper-64( 64 Cu), copper-67( 67 Cu), holmium-166( 166 Ho), lead-212( 212 Pb), Lutetium-177( 177 Lu), radium-223 ( 223 Ra), rhenium-186 ( 186 Re), rhenium-188 ( 188 Re), Samarium-153 ( 153 Sm), Strontium-89 ( 89 Sr), thorium-227( 227 Th) and Yttrium-90 ( 90 Y) The expression "radionuclide for use in radiotherapy" also covers combinations of two or more of the abovementioned radionuclides.

[0132] As used herein, the expression "radionuclide for PET imaging and radiotherapy" refers to actinium-225 ( 225 Ac), copper-62( 62 Cu), copper-64( 64 Cu), copper-67( 67 Cu), Gallium-68( 68 Ga), holmium-166( 166 Ho), lead-212( 212 Pb), Lutetium-177( 177 Lu), radium-223 ( 223 Ra), rhenium-186 ( 186 Re), rhenium-188 ( 188 Re), Rubidium-82( 82 Rb), Samarium-153 ( 153 Sm), Strontium-89 ( 89 Sr), thorium-227( 227 Th), Yttrium-90( 90 Y) and zirconium-89 ( 89 The expression "radionuclide for PET imaging and radiotherapy" also covers combinations of two or more of the abovementioned radionuclides.

[0133] As used herein, the expression "radionuclide for SPECT imaging and radiotherapy" refers to actinium-225 ( 225 Ac), copper-64( 64 Cu), copper-67( 67 Cu), Gallium-67( 67 Ga), holmium-166( 166Ho), indium-111( 111 In), lead-212( 212 Pb), Lutetium-177( 177 Lu), radium-223 ( 223 Ra), rhenium-186 ( 186 Re), rhenium-188 ( 188 Re), Samarium-153 ( 153 Sm), Strontium-89 ( 89 Sr), Technetium-99m( 99m Tc 3+ )、Thallium-201( 201 Tl), Thorium-227 ( 227 Th) and Yttrium-90 ( 90 Y) The expression "radionuclide for SPECT imaging and radiotherapy" also covers combinations of two or more of the abovementioned radionuclides.

[0134] Numerical ranges: Whenever used herein, unless otherwise indicated, numerical ranges such as "1 to 8" or "1-8" refer to each integer in the given range; for example, "1 to 8 carbon atoms" and "1-8 carbon atoms" mean that the alkyl group can be composed of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 8 carbon atoms. However, there are some exceptions that are obvious to those skilled in the art. In particular, herein, when a given range is used to express a molar ratio (e.g., a P / N molar ratio or a Si / P molar ratio in a nanostructure), a diameter or size, a pH, a time period, a concentration, an osmotic pressure, or a temperature, then the range also includes all decimals falling within the range, including the upper and lower limits.

[0135] As used herein, the term "resin" is defined as an insoluble organic material.

[0136] As used herein, the term (w / w) means weight / weight.

[0137] As used herein, the term (w / v) means weight / volume.

[0138] As used herein, the term (v / v) means volume / volume.

[0139] As used herein, 90.0% (v / v) aqueous ethylene glycol refers to a mixture of 90.0% (v / v) ethylene glycol and 10.0% (v / v) water. BRIEF DESCRIPTION OF THE DRAWINGS

[0140] By way of example, embodiments of the present teachings will now be described with reference to the accompanying drawings, in which:

[0141] Figure 1 is a diagram of a spherical object showing the minor and major axes.

[0142] Figure 2 is a diagrammatic representation of the structure of a coated nanostructure, which includes a central portion, an intermediate layer, and a coating layer.

[0143] Figure 3 A process scheme for the extractive purification process is shown.

[0144] Figure 4 A process scheme for preliminary extraction is shown.

[0145] Figure 5 A process scheme for intermediate extraction is shown.

[0146] Figure 6 The process scheme for product extraction is shown.

[0147] Figure 7 A process scheme for product purification is shown.

[0148] Figure 8 is a schematic representation of the extraction and purification, showing the whereabouts of the di-PEGylated diene during the extraction process.

[0149] Fig. 9 An example composition of the quenched reaction mixture from the synthesis of di-PEGylated diene 9b is shown.

[0150] Fig.10 Shown are HPLC-ELSD chromatograms of the reaction mixture from the synthesis of di-PEGylated diene 9 before (A) and after (B) extractive purification.

[0151] Fig.11 is a schematic representation of a coating precursor reacting with the surface of a nanostructure.

[0152] Fig.12 is a graph of tumor growth from the treatment group (diamonds) and the control group (squares) of Example 17.

[0153] Fig.13 Shown are compounds according to formula (I). DETAILED DESCRIPTION

[0154] The present application relates to chemical compounds (hereinafter referred to as "coating precursors") having the ability to form dense coatings on nanostructures. Specifically, they are suitable for forming dense coatings on nanostructures having silanol groups on their surfaces.

[0155] The compounds according to the present application offer a significant improvement over the prior art, as they can be synthesized on a large scale with high purity, as shown in Example 3.

[0156] These compounds further provide significant improvements over the prior art in forming nanostructured coatings. As shown in Example 16, nanostructures coated with coating precursors according to the present application have higher storage stability and more favorable in vivo performance than nanostructures coated with coating precursors outside the scope of the present application.

[0157] Furthermore, the nanostructure coated with the coating precursor according to the present application exhibited a remarkable effect in treating tumors (see Example 17).

[0158] Coating precursor and resulting coating include polymeric groups. As known to those skilled in the art, the polymer synthesized by most methods is not the same chemical entity, but includes a plurality of polymer molecules with different degrees of polymerization, degree of crosslinking and degree of branching. The degree of polymerization can be measured by mass spectrometry, gel filtration or dynamic light scattering. The degree of polymerization can be expressed as the number of monomer residues in the polymer, or can alternatively be expressed as the chain length or the molecular weight of the polymer. Unless otherwise indicated, the polymeric groups of the present application exist as the form of a mixture of polymeric groups with different degrees of polymerization.

[0159] The coating precursor according to the present application comprises reactive silane functional groups. This enables the coating precursor to form bonds with the surface comprising functional groups capable of forming bonds of the structure GO-Si, wherein G represents an atom in the surface, such as a silicon atom, and Si represents a silicon atom from a coating precursor molecule.

[0160] When the degree of polymerization is given in the form of a range, it will be understood by those skilled in the art that this means that a majority, such as a majority, such as more than 80%, or such as more than 90%, or such as more than 95% of the polymer molecules have a degree of polymerization that falls within the given range. It will also be understood that some small fraction of the polymer groups present may have a degree of polymerization outside the given range, and this may include degrees of polymerization above and below the given range. When the degree of polymerization is given as a single value, it will be understood that, unless otherwise stated, the value is to be understood as an average or typical degree of polymerization.

[0161] Coating precursor (compound according to the present application)

[0162] The present application relates to compounds according to formula (I):

[0163]

[0164] in

[0165] Poly 1 and Poly 2 independently selected from the group consisting of hydrogen and a hydrophilic polymer group with a molecular weight of 400Da to 10000Da; wherein Poly 1 or Poly 2At least one of the groups is a hydrophilic polymer group having a molecular weight of 400Da to 10000Da;

[0166] Y 1 and Y 2 is independently -A(CH2) n B-; among them

[0167] A binds to X binds;

[0168] Y 1 B in the binds to Poly 1 ;

[0169] Y 2 B in the binds to Poly 2 ;

[0170] n is an integer between 0 and 5;

[0171] A is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond; and

[0172] B is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)- and a covalent bond, provided that when Poly 1 or Poly 2 Zhong and Y 1 or Y 2 When the bonded atom is not a carbon atom, B is a covalent bond;

[0173] Y 3 and Y 4 is independently -E(CH2) m -;in,

[0174] E binds to X;

[0175] m is an integer between 2 and 5; and

[0176] E is independently selected from the group consisting of -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond; and

[0177] X is selected from the structure X 1 , X 2 , X 3 , X 4 and X 5 The group composed of

[0178]

[0179] in

[0180] Bold keys are bound to Y 1 or Y 2 Keys;

[0181] Non-bold bonds are bound to Y 3 or Y 4 and

[0182] p is an integer between 1 and 5;

[0183] and

[0184] Z 1 and Z 2 Independently -SiR 1 R 2 R 3 ,in,

[0185] R 1 , R 2 and R 3 are independently selected from chlorine, bromine, iodine, lower alkoxy, aryloxy, carboxyl, amino and

[0186] -NH-acyl group.

[0187] When considering the above structures, if two or more covalent bonds are connected in series, they should be interpreted together as one bond.

[0188] Poly 1 and Poly 2

[0189] Poly 1 and / or Poly 2 Capping groups suitable for further derivatization may be included and include carboxylic acids, amines, activated esters, azides, thiols, N-succinimide, epoxides, double bonds, and alkynes.

[0190] Poly 1 and Poly 2 All of them can be hydrophilic polymer groups with a molecular weight of 400Da to 10000Da.

[0191] Poly 1 and / or Poly 2 Polyethers may be included.

[0192] Preferably, Poly 1 and / or Poly 2 Includes polyethylene glycol. 1 and Poly 2On average, the ethylene glycol units may include 10 to 200, such as 12 to 170, such as 15 to 120, such as 20 to 90, such as 30 to 75, such as 35 to 60, such as 40 to 50, such as 12 to 170, such as 75 to 170, such as 60 to 120, such as 50 to 90, such as 30 to 60, such as 20 to 50, or such as 12 to 30.

[0193] The polyethylene glycol chain may be terminated by a hydroxy group or a lower alkyl group such as a methyl or ethyl group.

[0194] Alternatively, the polyethylene glycol chain may be terminated by a carboxylate group (such as a -CH2-C(O)-O-tBu group) or an amide group.

[0195] In a preferred embodiment, each polyethylene glycol chain contains 20 to 150 ethylene glycol residues and each polyethylene glycol chain is terminated with a methyl group.

[0196] In one embodiment, Poly 1 and Poly 2 Polyethylene glycol is included, and each ethylene glycol chain is terminated by a methyl group, and the number of ethylene glycol residues per polymer group is 10 to 200, such as 12 to 170, such as 15 to 120, such as 20 to 90, such as 30 to 75, such as 35 to 60, such as 40 to 50, such as 12 to 170, such as 75 to 170, such as 60 to 120, such as 50 to 90, such as 30 to 60, such as 20 to 50, or such as 12 to 30 ethylene glycol units.

[0197] Specifically, Poly 1 and Poly 2 Polyethylene glycol may be included wherein each polyethylene glycol chain is terminated with a methyl group and the average number of ethylene glycol residues per polymer group is between 42 and 48.

[0198] Poly 1 and / or Poly 2 It can also include block copolymers of polyethylene glycol and one or more polymers. 1 and / or Poly 2 Polymer groups derived from the copolymerization of ethylene oxide and other monomers may be included.

[0199] In some embodiments, Poly 1 and / or Poly 2 These include polyoxazolines such as polymethyloxazoline or polyethyloxazoline.

[0200] In some embodiments, Poly 1 and Poly 2Included are polymethyloxazolines, each polymer group is terminated with a lower alkyl group, and each polymer group includes 12 to 120 monomer residues.

[0201] In some embodiments, Poly 1 and Poly 2 Included are polyethyloxazolines, each polymer group is terminated with a lower alkyl group, and each polymer group includes 10 to 100 monomer residues.

[0202] In some embodiments, Poly 1 and / or Poly 2 Includes polyglycerol.

[0203] In some embodiments, Poly 1 and Poly 2 Polyglycerol is included and is linear or substantially linear.

[0204] In some embodiments, Poly 1 and Poly 2 Polyglycerol is included, and the polyglycerol is branched, such as hyperbranched.

[0205] In some embodiments, Poly 1 and / or Poly 2 Includes polyvinylpyrrolidone.

[0206] In some embodiments, Poly 1 and / or Poly 2 Includes polyamide.

[0207] In some embodiments, Poly 1 and Poly 2 Includes polyglycine.

[0208] In some embodiments, Poly 1 and Poly 2 Included are polymer groups of the structure -[NH-CH(O-{mPEG})-C(O)]-, wherein mPEG is methyl-terminated polyethylene glycol.

[0209] In some embodiments, Poly 1 and Poly 2 Including peptoids.

[0210] Y 1 and Y 2

[0211] Y 1 and Y 2 Can be the same or different.

[0212] In one embodiment, n is an integer between 1 and 3. Preferably, n is 1 or 2, even more preferably n is 1.

[0213] In one embodiment, Y 1 and Y 2 The n in is always 1.

[0214] In a specific embodiment, Y 1 and Y 2 A in which is a covalent bond, and B is a covalent bond or -O-, and n is 2.

[0215] Preferably, in Y 1 and Y 2 In this embodiment, A is a covalent bond, B is -O-, and n is 1.

[0216] In another embodiment, in Y 1 In which A is a covalent bond, B is a covalent bond or -O-, and n is 1; and in Y 2 In the formula (A), A is a covalent bond, B is a covalent bond or -O-, and n is 2.

[0217] In another embodiment, in Y 1 In which A is a covalent bond, B is a covalent bond or -O-, and n is between 1 and 3; and in Y 2 In this case, A and B are covalently bonded, n is 0, and Poly 2 It's H.

[0218] In yet another embodiment, Y 1 and Y 2 In one or both of the above, A is a covalent bond and B is -O-, -S-, -N-, -C(=O)O-, -C(=O)NH-, -O(C=O)- or -NH(C=O)-.

[0219] In another embodiment, in Y 1 or Y 2 In one of the above, A is a covalent bond, and in Y 1 or Y 2 In another embodiment, A is -O-, -S-, -N-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, or -NH(C=O)-.

[0220] In another embodiment, in Y 1 and Y 2 wherein A is -O-, -S-, -N-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, or -NH(C=O)-; and X is X 3 or X 5 .

[0221] As expected, Y 1 and / or Y 2 It may also have a structure different from the above structure. 1 and / or Y 2 The alkyl portion of may be further substituted, for example Y 1 and / or Y 2 The alkyl portion of is branched or substituted by a group such as F or methoxy.

[0222] Y 3 and Y 4

[0223] Y 3 and Y 4 can be the same or different. Specifically, Y 3 and Y 4 The m in may be the same or different.

[0224] In one embodiment, in Y 3 and Y 4 In the formula, E is a covalent bond and m is between 2 and 5.

[0225] In a specific embodiment, in Y 3 and Y 4 , E is a covalent bond, and m is 3.

[0226] In another specific embodiment, in Y 3 and Y 4 In this case, E is a covalent bond and m is 4.

[0227] In another specific embodiment, in Y 3 and Y 4 In this example, E is a covalent bond and m is 5.

[0228] Therefore, preferably, Y 3 and Y 4 E in the equation is a covalent bond, and Y 3 and Y 4 The m in can be the same or different. For example, in a specific embodiment, Y 3 and Y 4 E in is a covalent bond, Y 3 where m is between 2 and 5, and Y 4 The m in the formula is between 2 and 5, but is not related to Y 3 The m value is different.

[0229] In some embodiments, for Y 3 and Y 4 one of the following, E is -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, or -NH(C=O)-, and for Y3 and Y 4 The other one in, E is a covalent bond.

[0230] In other embodiments, for Y 3 and Y 4 , E is -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, or -NH(C=O)-; and X is X 3 or X 5 .

[0231] As expected, Y 3 and / or Y 4 The alkyl portion of 3 and / or Y 4 The alkyl portion of is branched or substituted by a group such as F or methoxy.

[0232] It is also expected that Y 3 and / or Y 4 The alkyl portion of the alkyl group may contain heteroatoms such as O or S.

[0233] Z 1 and Z 2

[0234] In one embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 is a halogen. The halogen may be Cl and / or Br.

[0235] Therefore, in a specific embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 It is Cl.

[0236] In another specific embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 It's Br.

[0237] In one embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 Preferably, the lower alkoxy group is methoxy, ethoxy and / or isopropoxy.

[0238] Therefore, in a specific embodiment, Z 1 and Z2 R 1 , R 2 and R 3 It's a methoxy group.

[0239] In another specific embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 It is ethoxy.

[0240] In another specific embodiment, Z 1 and Z 2 R 1 , R 2 and R 3 It is isopropoxy.

[0241] Alternatively, Z 1 and Z 2 The R-groups on the NH4-H-S are a mixture of Cl and lower alkoxy.

[0242] Specific coating precursors

[0243] Some non-limiting examples of specific coating precursors are listed below.

[0244] Y 1 and Y 2 and Poly 1 and Poly 2 A specific combination of

[0245] In some embodiments, for Y 1 and Y 2 Both, A is a covalent bond, B is a covalent bond or -O-, and n is 1 or 2; and Poly 1 and Poly 2 Including polyether. The polyether is as described above. Preferably, the polyether is polyethylene glycol.

[0246] In some embodiments, for Y 1 and Y 2 Both, A is a covalent bond, B is -O-, and n is 1 or 2; and Poly 1 and Poly 2 Included are polyethylene glycols wherein each polyethylene glycol chain contains 20 to 150 ethylene glycol residues and each PEG chain is terminated with a methyl group.

[0247] In a preferred embodiment, for Y 1 and Y 2 In both, A is a covalent bond, B is -O-, and n is 1; and Poly 1 and Poly 2Included are polyethylene glycols wherein each polyethylene glycol chain is terminated with a methyl group and the number of ethylene glycol residues in each polymer group is between 12 and 170, such as between 20 and 120, such as between 30 and 90, such as between 40 and 75, such as between 50 and 60.

[0248] In a preferred embodiment, for Y 1 and Y 2 In both, A is a covalent bond, B is -O-, and n is 1; and Poly 1 and Poly 2 Included are polyethylene glycols wherein each polyethylene glycol chain is terminated with a methyl group and the number of ethylene glycol residues in each polymer group is between 12 and 30, or between 20 and 50, or between 30 and 60, or between 60 and 120, or between 75 and 170.

[0249] In one embodiment, for Y 1 , A is a covalent bond, B is -O-, and n is between 1 and 3, and for Y 2 , A and B are covalently bonded, and n is 0, and Poly 1 is a polyethylene glycol comprising between 20 and 150 ethylene glycol residues and terminated with methyl groups, and Poly 2 It's H.

[0250] It is also expected that Y 1 and Y 2 Either or both of these and Poly 1 or Poly 2 The connection between may also have other structures besides the above structures. The alternative structure may include a triazole connection.

[0251] Y 1 and Y 2 and Y 3 and Y 4 A specific combination of

[0252] In one embodiment, for Y 1 and Y 2 , A is a covalent bond, B is -O-, and n is 1 or 2; and for Y 3 and Y 4 , E is a covalent bond, and m is between 2 and 4.

[0253] In a preferred embodiment, for Y 1 and Y 2 , A is a covalent bond, B is -O-, and n is 1; and for Y 3 and Y 4 , E is a covalent bond, and m is 3.

[0254] Y 1 and Y 2 , X, Poly 1 and Poly 2 A specific combination of

[0255] In one embodiment, for Y 1 and Y 2 , A is a covalent bond, B is -O-, and n is 1 or 2; X is X 1 or X 2 ;Poly 1 and Poly 2 Included are polyethylene glycols wherein each polyethylene glycol chain is terminated with a methyl group and the number of ethylene glycol residues in each polymer group is between 12 and 170, such as between 20 and 120, such as between 30 and 90, such as between 40 and 75, such as between 50 and 60.

[0256] In one embodiment, for Y 1 and Y 2 , A is a covalent bond, B is -O-, and n is 1 or 2; X is X 1 or X 2 ;Poly 1 and Poly 2 Included are polyethylene glycols wherein each polyethylene glycol chain is terminated with a methyl group and the number of ethylene glycol residues in each polymer group is between 12 and 30, or between 20 and 50, or between 30 and 60, or between 50 and 90, or between 60 and 120, or between 75 and 170.

[0257] In another embodiment, for Y 1 and Y 2 , A is -O-, -S-, -C(=O)O- or -O(C=O)-, and n is 0 or 2 to 5; X is X 3 or X 5 ;Poly 1 and Poly 2 Includes polyethylene glycol in which each PEG chain is terminated with a methyl group.

[0258] In another embodiment, for Y 1 and Y 2 , A is -C(=O)O- or -O(C=O)-, and n is 0; X is X 1 , X 2 or X 4 ;Poly 1 and Poly 2 Includes polyethylene glycol in which each PEG chain is terminated with a methyl group.

[0259] Y 3 and Y 4 A specific combination of X

[0260] In one embodiment, for Y 3 and Y 4, E is -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, or -NH(C=O)-; and X is X 3 or X 5 .

[0261] In another embodiment, for Y 3 and Y 4 , E is a covalent bond, and m is 3, and X is X 1 , X 2 or X 4 .

[0262] Y 1 and Y 2 , X, and Y 3 and Y 4 A specific combination of

[0263] In one embodiment, for Y 1 , A is a covalent bond, B is a covalent bond or -O-, n is 1; for Y 2 , A and B are covalent bonds, n is 0; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3.

[0264] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 4 , and p is 1; for Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, and m is 3.

[0265] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 5; for Y 4 , E is a covalent bond, and m is 5.

[0266] In yet another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 5; for Y 4 , E is a covalent bond, and m is 4.

[0267] In another embodiment, for Y1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 2; for Y 4 , E is a covalent bond, and m is 2.

[0268] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 0; for Y 2 , A is a covalent bond, and B is -O-, n is 0; X is X 3 For Y 3 , E is a covalent bond, and m is 2; for Y 4 , E is a covalent bond, and m is 2.

[0269] In one embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 4 , and p is 1; for Y 3 , E is a covalent bond, and m is 4; for Y 4 , E is a covalent bond, and m is 4.

[0270] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 4 , and p is 1; for Y 3 , E is a covalent bond, and m is 2; for Y 4 , E is a covalent bond, and m is 2.

[0271] In a preferred embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, and m is 3.

[0272] Y 1 and Y 2 , X, Y 3 and Y 4 , and Poly 1 and Poly 2 A specific combination of

[0273] In one embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A and B are covalent bonds, n is 0; X is X 1 For Y3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 It's H.

[0274] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1 to 3; for Y 2 , A is a covalent bond, B is -O-, n is 1 to 3; X is X 4 , and p is 1 to 3; for Y 3 , E is a covalent bond, and m is 3 or 4; and for Y 4 , E is a covalent bond, and m is 3 or 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 Included are polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups.

[0275] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is between 2 and 5; and for Y 4 , E is a covalent bond, and m is between 2 and 5; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 Included are polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups.

[0276] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 0; for Y 2 , A is a covalent bond, B is -O-, n is 0; X is X 3 For Y 3 , E is a covalent bond, and m is between 2 and 4; and for Y 4 , E is a covalent bond, and m is between 2 and 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 Included are polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups.

[0277] In another embodiment, for Y 1 , A is a covalent bond, B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 4 , and p is 1 to 3; for Y 3 , E is a covalent bond, and m is between 2 and 4; and for Y 4 , E is a covalent bond, and m is between 2 and 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 Included are polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups.

[0278] In a preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 Included are polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups.

[0279] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 and Poly 2 Included are polyethylene glycols wherein each PEG chain is terminated with a methyl group and the number of ethylene glycol residues per polymer group is between 12 and 170, such as between 20 and 120, such as between 30 and 90, such as between 40 and 75, such as between 50 and 60.

[0280] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 and Poly 2 Included are polyethylene glycols wherein each PEG chain is terminated with a methyl group and the number of ethylene glycol residues per polymer group is between 12 and 30, or between 20 and 50, or between 30 and 60, or between 50 and 90, or between 60 and 120, or between 75 and 170.

[0281] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 and Poly 2 Includes polyethylene glycol wherein each PEG chain is terminated with a methyl group and the average number of ethylene glycol residues per polymer group is between 42 and 48.

[0282] Y 1 and Y 2 , X, Y 3 and Y 4 、Poly 1 and Poly 2 , and Z 1 and Z 2 A specific combination of

[0283] In one embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A and B are covalent bonds, n is 0; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 is H; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0284] In another embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1 to 3; for Y 2, A is a covalent bond, and B is -O-, n is 1 to 3; X is X 4 , and p is 1 to 3; for Y 3 , E is a covalent bond, and m is 3 or 4; and for Y 4 , E is a covalent bond, and m is 3 or 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 comprising polyethylene glycol containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0285] In another embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is between 2 and 5; and for Y 4 , E is a covalent bond, and m is between 2 and 5; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 comprising polyethylene glycol containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0286] In another embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 0; for Y 2 , A is a covalent bond, and B is -O-, n is 0; X is X 3 For Y 3 , E is a covalent bond, and m is between 2 and 4; and for Y 4, E is a covalent bond, and m is between 2 and 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 comprising polyethylene glycol containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0287] In another embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 4 , and p is 1 to 3; for Y 3 , E is a covalent bond, and m is between 2 and 4; and for Y 4 , E is a covalent bond, and m is between 2 and 4; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2 comprising polyethylene glycol containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0288] In a preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 including polyethylene glycols containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and 2comprising polyethylene glycol containing 20 to 150 ethylene glycol residues and terminated with methyl groups; and for Z 1 , R 1 , R 2 and R 3 is chlorine or lower alkoxy, such as methoxy or ethoxy; and for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0289] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, m is 3; and Poly 1 and Poly 2 comprising polyethylene glycol, wherein each polyethylene glycol chain is terminated by a methyl group, and the number of ethylene glycol residues in each polymer group is between 12 and 170, such as between 20 and 120, such as between 30 and 90, such as between 40 and 75, such as between 50 and 60; for Z 1 , R 1 , R 2 and R 3 is chlorine or a lower alkoxy group, such as methoxy or ethoxy; for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0290] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, m is 3; and Poly 1 and Poly 2 comprising polyethylene glycol, wherein each polyethylene glycol chain is terminated by a methyl group, the number of ethylene glycol residues per polymer group being between 12 and 30, or between 20 and 50, or between 30 and 60, or between 50 and 90, or between 60 and 120, or between 75 and 170; for Z 1 , R1 , R 2 and R 3 is chlorine or a lower alkoxy group, such as methoxy or ethoxy; for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0291] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, m is 3; and Poly 1 and Poly 2 comprising polyethylene glycol, wherein each PEG chain is terminated by a methyl group, and the average number of ethylene glycol residues per polymer group is about 45, such as between 42 and 48; for Z 1 , R 1 , R 2 and R 3 is chlorine or a lower alkoxy group, such as methoxy or ethoxy; for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0292] In one embodiment, for Y 1 , A and B are covalent bonds, n is 1; for Y 2 , A and B are covalent bonds, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; and for Y 4 , E is a covalent bond, and m is 3; and Poly 1 and Poly 2 Including polyoxazolines, such as polymethyloxazoline or polyethyloxazoline, wherein each polymer chain is terminated by a lower alkyl group (such as methyl or ethyl); 1 , R 1 , R 2 and R 3 is chlorine or a lower alkoxy group, such as methoxy or ethoxy; for Z 2 , R 1 , R 2 and R 3 It is chlorine or a lower alkoxy group such as methoxy or ethoxy.

[0293] In a preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, m is 3; and Poly 1 and Poly 2 is polyethylene glycol, wherein each polyethylene glycol chain is terminated by a methyl group, and the average number of ethylene glycol residues per polymer group is about 45, such as between 42 and 48; and for Z 1 and Z 2 , R 1 , R 2 and R 3 It is ethoxy.

[0294] In another preferred embodiment, for Y 1 , A is a covalent bond, and B is -O-, n is 1; for Y 2 , A is a covalent bond, and B is -O-, n is 1; X is X 1 For Y 3 , E is a covalent bond, and m is 3; for Y 4 , E is a covalent bond, m is 3; and Poly 1 and Poly 2 is polyethylene glycol, wherein each polyethylene glycol chain is terminated with a methyl group, and the average number of ethylene glycol residues per polymer group is between 65 and 72; and for Z 1 and Z 2 , R 1 , R 2 and R 3 It is ethoxy.

[0295] Method for preparing precursor

[0296] The present application also relates to a method of preparing the coating precursor.

[0297] The method can be used at various scales, e.g., from small laboratory scale to kilogram preparation scale and beyond, which offers a clear advantage over alternative methods that are only suitable for certain limited scales.

[0298] When the coating precursors of the present application are used to coat nanostructures (described in more detail below), if the coating precursors have a high purity (e.g., at least 90% purity), this produces coated nanostructures having, for example, a longer plasma half-life and better storage stability than when the coating precursors have a lower purity.

[0299] Advantageously, the present method produces a coating precursor of such purity that when the coating precursor is used to coat a nanostructure, the resulting coated nanostructure is of high quality, has desired in vivo properties and has desired storage stability.

[0300] Purification of the finished coating precursor is difficult due to the nature of the coating precursor. Many common methods used for purification of chemical compounds are not suitable for the coating precursors of the present application.

[0301] Since the compound includes a polymer group, and the polymer group usually exists in a variety of chain lengths, it is difficult to purify by crystallization. In addition, since the compound includes a polymer group, the compound is non-volatile or substantially non-volatile, and purification by distillation and / or sublimation is impossible or substantially impossible.

[0302] These compounds also include reactive silane groups, making them unsuitable for most commonly used chromatography purification techniques. Reactive silane groups bind to surfaces containing silanol functionalities and form strong bonds. Therefore, chromatography using silica and similar materials as stationary phases (commonly known as normal phase chromatography) is difficult because a significant portion of the material to be purified is irreversibly bound to the stationary phase and therefore cannot be eluted.

[0303] Reactive silane groups are sensitive to hydrolysis and self-condensation reactions in the presence of water. Therefore, chromatography using hydrophobic materials as stationary phase and aqueous mobile phase (commonly known as reverse phase chromatography) is difficult because a significant portion of the material to be purified will hydrolyze and / or oligomerize during the chromatography process.

[0304] The process of the present application has the advantage that it produces coating precursors of sufficient purity for producing high quality coated nanostructures without requiring further purification of the coating precursor beyond removal of catalyst residues and evaporation of volatile solvents and reagents.

[0305] According to this method, by using a structure of H-SiR 1 R 2 R 3 The olefin moiety is hydrosilylated by a reagent, which effectively introduces a silane group into the coating precursor molecule, wherein R 1 , R 2 and R 3 As defined in formula (I) above, that is, R 1 , R 2 and R 3Independently selected from the group consisting of chlorine, bromine, iodine, lower alkoxy, aryloxy, carboxyl, amino and -NH-acyl. It is clear to those skilled in the art that in order to obtain the product of formula (I), the hydrosilylation reaction must be carried out on a substrate having two olefinic moieties, i.e., a diene.

[0306] Furthermore, it has been found that the introduction of polymeric groups is most effectively accomplished prior to the introduction of silane groups. Thus, the introduction of silane groups by hydrosilylation is accomplished by hydrosilylation of the diene which is the polymeric diene conjugate.

[0307] Hydrosilylation is usually achieved by using a catalyst. The catalyst can be a platinum catalyst, such as a platinum (0) compound, such as a Karstedt catalyst. It is known in the art that when such catalysts are used for hydrosilylation, several side reactions may occur. Such side reactions include reduction of olefin double bonds and migration of olefin double bonds. It is known that hydrosilylation reactions on internal double bonds are significantly slower than hydrosilylation reactions on terminal double bonds.

[0308] Specifically, for synthesizing a coating precursor according to formula (I), wherein Poly 1 and Poly 2 is polyethylene glycol, each polyethylene glycol chain is terminated by a lower alkyl group; wherein, for Y 1 , A is a covalent bond, and B is -O-, and n is between 1 and 3; for Y 2 , A is a covalent bond, and B is -O-, and n is between 1 and 3; and wherein, for Y 3 , E is a covalent bond, and m is between 2 and 5; for Y 4 , E is a covalent bond, and m is between 2 and 5; and wherein, for Z 1 , R 1 , R 2 and R 3 is a lower alkoxy group; for Z 1 , R 1 , R 2 and R 3 is a lower alkoxy group suitable for hydrosilylation of a diene according to formula (II):

[0309]

[0310] Among them, R 7 and R 8 is independently selected as a lower alkyl group; p is an integer between 20 and 150; q is an integer between 20 and 150, preferably 30 to 60, or 40 to 50; r is an integer between 1 and 3; s is an integer between 1 and 3; t is an integer between 0 and 3; u is an integer between 0 and 3; and X is selected from X1 , X 2 , X 3 , X 4 and X 5 The groups consist of:

[0311]

[0312] The bold bonds represent the bonds with [CH2] r and [CH2] s Bonds that are not in bold indicate bonds to [CH2] t and [CH2] u The bond to be bonded; and p is an integer between 1 and 5.

[0313] The present application therefore also relates to such dienes (described in detail below).

[0314] Preferably, p is an integer between 30 and 60, even more preferably, an integer between 40 and 50.

[0315] Preferably, q is an integer between 30 and 60, even more preferably, an integer between 40 and 50.

[0316] When considering the above structures, if two or more covalent bonds are connected in series, they should be interpreted together as one bond.

[0317] It is noteworthy that when the diene according to formula (II) is subjected to standard hydrosilylation conditions to the structure HSiR 1 R 2 R 3 (Among them, R 1 , R 2 and R 3 When hydrosilylation is performed with a hydrosilylation agent (e.g., a lower alkoxy group), a significant amount of impurities are generated. Example 16 shows the results of an unsuccessful synthesis using standard hydrosilylation conditions.

[0318] Examples of these impurities include hydrogenation products of one or both of the double bonds in the structure of formula (II) and products of double bond migration reactions. Example 19 gives an example of an attempt to synthesize compound 10 using standard hydrosilylation conditions, and Fig.10 A chromatogram showing the composition of the product of Example 19 is depicted in .

[0319] It has been found that when a coating precursor containing a large amount of by-products formed from dienes but comprising only one silane group is used to coat nanostructures, the resulting coated nanostructures have inferior properties, such as a shorter in vivo circulation time and lower stability, i.e., loss of the coating. Furthermore, due to the relatively high costs involved, the coating precursor can only be separated from the by-product comprising only one silane group by chromatography under chromatography conditions that are not suitable for large-scale production of the coating precursor.

[0320] However, surprisingly, when the diene of formula (II) is replaced by the structure HSiR 1 R 2 R 3 (Among them, R 1 , R 2 and R 3 When the hydrosilylation is carried out with a hydrosilylation agent (which is a lower alkoxy group) and the hydrosilylation agent is present in an excess of more than 30 equivalents relative to the diene, the formation of impurities including less than two silane groups is significantly reduced.

[0321] Therefore, the present application also relates to a method for preparing the compound of the present application, wherein Poly 1 and Poly 2 The hydrophilic polymer group comprises a PEG chain, wherein each PEG chain is terminated by a lower alkyl group, and wherein the hydrophilic polymer group comprises a PEG chain optionally terminated by a lower alkyl group, optionally wherein each hydrophilic polymer group comprises 20 to 150 ethylene glycol residues; or wherein the Poly 1 and Poly 2 It is ω-methyl-(ethyleneoxy) w , and w is 20 to 150, preferably 30 to 60; in Y 1 and Y 2 In which A is a covalent bond, B is -O-, and n is 1; Y 3 and Y 4 are -CH2-CH2-CH2-; X is X 1 ; and Z 1 and Z 2 Independently selected from triethoxysilyl and trimethoxysilyl.

[0322] Specifically, the method comprises the following steps:

[0323] i) providing a diene according to formula (II) above, optionally purified as described below;

[0324] ii) reacting a diene with at least 30 equivalents of a compound having the structure HSiR in the presence of a platinum catalyst and an aromatic hydrocarbon solvent at a temperature of 10°C to 35°C 1 R 2 R3 contacting with a hydrosilylation agent, wherein R 1 , R 2 and R 3 independently selected from the group consisting of lower alkoxy;

[0325] iii) removing excess hydrosilylation agent; and

[0326] iv) Removal of platinum from the product.

[0327] When nanostructures are coated with a coating precursor prepared in this manner, the resulting coated nanostructures will be of high quality.

[0328] The diene provided in step i) may have a purity of at least 95%.

[0329] Typically, when the diene provided in step i) of the process has a purity of at least 95%, the resulting coating precursor has a purity of at least 90%.

[0330] Preferably, the alkoxy groups in step ii) are methoxy and / or ethoxy groups.

[0331] In particular, when the diene used in the hydrosilylation reaction has a high purity, such as greater than 90%, such as greater than 95%, or such as greater than 97%, and the hydrosilylation agent is present in more than 30 equivalents, such as 40 equivalents, the resulting coating precursor has a high purity, such as greater than 90%, such as greater than 95%. The coating precursor prepared under such conditions contains only a limited amount of by-products including less than 2 silane groups, such as less than 10%, or less than 5%, or less than 3%, or less than 1% of the amount of the coating precursor. When a nanostructure is coated with a coating precursor prepared in this manner, the resulting coated nanostructure will have a particularly high quality.

[0332] In Examples 2, 3, 4, 5, 7, 8 and 9, examples of methods employed to produce high purity coating precursors are shown.

[0333] Alternatively, if the impurities present in the diene are of such a nature that they do not interfere with coating the nanostructures with the coating precursor and of such a nature that they do not interfere with the hydrosilylation, the diene used in the hydrosilylation can have a lower purity. Impurities known to interfere neither with coating the nanostructures with the coating precursor nor with the hydrosilylation include polymers of the structures mPEG2O and mPEG.

[0334] In the diene according to formula (II), R 7 and R 8 It can be methyl, ethyl, isopropyl, n-propyl or tert-butyl. 7 and R 8It's methyl.

[0335] In the diene according to formula (II), r and s may be 1.

[0336] In the diene according to formula (II), t and u may be 1.

[0337] The solvent used in step ii) may be toluene or xylene, or a mixture comprising toluene or xylene.

[0338] Preferably, the solvent in step ii) is toluene or xylene.

[0339] Furthermore, it is often advantageous to dry the diene before contacting it with the hydrosilylation agent. This can be conveniently achieved by azeotropic distillation of a solution of the diene in the reaction solvent. The azeotropic distillation can be carried out in a vessel which can subsequently be used as a reaction vessel for the hydrosilylation.

[0340] The catalyst in step ii) can be a platinum (0) compound, such as Karstedt's catalyst. Alternatively, other platinum catalysts such as K2PtCl6 can also be used.

[0341] The concentration of diene in step ii) is advantageously high, for example greater than 10% (w / v).

[0342] In step ii), a catalyst loading of between 0.5 mol % and 3 mol %, for example between 1 mol % and 2 mol %, relative to the diene is suitable.

[0343] It is often convenient to first contact the diene and the hydrosilylation agent in the presence of a reaction solvent prior to introducing the catalyst. This is conveniently achieved by mixing an azeotropically dried diene solution with the hydrosilylation agent.

[0344] Typically, an exotherm is observed upon introduction of the catalyst. In this case, it is convenient to introduce the catalyst slowly, for example by portionwise addition or slowly injecting the catalyst solution into the solution of the diene and hydrosilylation agent.

[0345] The hydrosilylation agent used in step ii) may be trimethoxysilane, triethoxysilane or triisopropoxysilane.

[0346] In a specific embodiment, the hydrosilylation agent used in step ii) is trimethoxysilane.

[0347] In another specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane.

[0348] In yet another specific embodiment, the hydrosilylation agent used in step ii) is triisopropoxysilane.

[0349] The hydrosilylation agent used in step ii) may be present in more than 30 equivalents, such as in 40 equivalents, or such as in more than 40 equivalents.

[0350] The catalyst used in step ii) may be a platinum (0) compound. Preferably, the catalyst used in step ii) is a platinum (0) compound, free of chlorine or substantially free of chlorine.

[0351] In one embodiment, the catalyst used in step ii) is a Karstedt catalyst.

[0352] When step ii) is carried out at a temperature of 20°C to 25°C, the reaction is typically complete or substantially complete within one hour after the addition of the catalyst.

[0353] The presence of unreacted hydrosilylation agent is detrimental to the removal of platinum by the thiol-derivatized polystyrene resin. Therefore, in step iii), the excess hydrosilylation agent is removed.

[0354] The unreacted silane reagent can be completely or substantially completely removed from the coating precursor by distilling the hydrosilylating agent from the reaction mixture, particularly by repeating co-distillation with the solvent to achieve. Preferably, the reaction mixture is first concentrated, for example by using a rotary evaporator or for example by vacuum distillation from a reaction vessel, thereby producing a residue comprising a significant amount of unreacted silane reagent. The residue is then repeatedly redissolved in an aromatic hydrocarbon solvent (such as toluene or xylene), and the concentration process is repeated, and each repetition of the dissolving-concentrating cycle produces a residue with a lower concentration of unreacted hydrosilylating agent. Usually 3 to 8 dissolving-concentrating cycles are enough to produce a residue that does not contain or is substantially free of unreacted hydrosilylating agent. Advantageously, the dissolving-concentrating process is repeated under dry conditions.

[0355] Since the coating precursor is non-volatile or substantially non-volatile, it is not feasible to separate the coating precursor from the catalyst and residues derived from the catalyst by distilling the silylation product, as is standard practice for many silylation materials. However, there are several methods for carrying out step iv), some of which are described below.

[0356] Removing platinum from a coating precursor by a material having an affinity for platinum, and separating the coating precursor and the scavenging material by physical methods (such as filtration) is a satisfactory method for removing platinum from a coating precursor. In particular, it has been found that mercaptan-derived polystyrene resins can be used to remove platinum from a coating precursor. It has also been found that activated carbon is also useful. Examples of other scavenging materials are materials such as comprising thiourea groups, or materials comprising phosphine groups. Other possible scavenging materials are known to those skilled in the art.

[0357] Thus, contacting a toluene solution of the coating precursor with a thiol-derivatized polystyrene resin at between 45° C. and 75° C. typically reduces the concentration of platinum to very low levels, e.g., less than 10 ppm as measured by ICP-OES, within a few days. If satisfactory platinum removal is not achieved within a few days, the solution is separated from the thiol-derivatized polystyrene resin and treated with fresh thiol-derivatized polystyrene resin or with activated carbon, typically resulting in satisfactorily low platinum levels. Multiple treatments with thiol-derivatized polystyrene resin and / or charcoal may be performed if desired.

[0358] In one embodiment, at the end of the hydrosilylation reaction, the platinum present is removed by scavenging with a thiolated polystyrene resin.

[0359] In another embodiment, at the end of the hydrosilylation reaction, the platinum present is removed by scavenging with a scavenging material comprising carbon, such as activated carbon.

[0360] In yet another embodiment, at the end of the hydrosilylation reaction, the platinum present is removed by a combination of scavenging with a thiolated polystyrene resin and scavenging with a scavenging material including carbon.

[0361] In Examples 2c, 3b, 4b, 5b, 6b, 7d and 9d, several examples of the application of the current coating precursor synthesis method are shown.

[0362] Specific embodiments of the method for preparing the coating precursor

[0363] Some embodiments of the method use a diene according to formula (II) wherein R 7 and R 8 is a methyl group, and p and q are between 30 and 60.

[0364] Some embodiments of the method use a diene according to formula (II) wherein R 7 and R 8 is a methyl group, and p and q are between 50 and 70.

[0365] Some embodiments of the method use a diene according to formula (II) wherein R 7and R 8 is methyl, p and q are between 30 and 60, and r and s are 1.

[0366] Some embodiments of the method use a diene according to formula (II) wherein R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, and t and u are 1.

[0367] Some embodiments of the method use a diene according to formula (II) wherein R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 .

[0368] In one embodiment, the hydrosilylation agent used in step ii) is triethoxysilane and is present in 40 equivalents.

[0369] In another embodiment, the hydrosilylation agent used in step ii) is triethoxysilane and, for the diene, t and u are 1.

[0370] In yet another embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and for the diene, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, and t and u are 1.

[0371] In yet another embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and for the diene, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 .

[0372] In one embodiment, the catalyst used in step ii) is a platinum compound comprising 1,1,3,3-tetramethyl-1,3-divinyldisiloxane and further comprising other ligands coordinated to the platinum.

[0373] In a specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and the triethoxysilane is present in 35 to 45 equivalents, and for the diene, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 , and the solvent is toluene.

[0374] In another specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and the triethoxysilane is present in 35 to 45 equivalents, and for the diene, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 , and the solvent is toluene, the concentration of diene is 10% (w / v) to 20% (w / v), the catalyst is Karstedt catalyst, the catalyst loading is 1 mol% to 2 mol%, and the reaction temperature is 18°C ​​to 28°C.

[0375] In yet another specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and the triethoxysilane is present in 35 to 45 equivalents, the solvent is toluene, and the excess triethoxysilane is removed by repeated co-distillation with toluene.

[0376] In yet another specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and the triethoxysilane is present in 35 to 45 equivalents, the solvent is toluene, and the excess triethoxysilane is removed by repeated co-distillation with xylene.

[0377] In another specific embodiment, the hydrosilylation agent used in step ii) is triethoxysilane, and the triethoxysilane is present in 35 to 45 equivalents, and for the diene, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 , and the solvent is toluene, the concentration of diene is 10% (w / v) to 20% (w / v), the catalyst is Karstedt catalyst, the catalyst loading is 1 mol% to 2 mol%, the reaction temperature is 18°C ​​to 28°C, excess triethoxysilane is removed by repeated co-distillation with toluene or xylene, and platinum is removed by scavenging through a thiolated polystyrene resin.

[0378] Di-PEGylated Diene

[0379] As mentioned above, the present application also relates to compounds according to formula (II):

[0380]

[0381] Among them, R 7 and R 8independently selected from lower alkyl; p is an integer between 20 and 150; q is an integer between 20 and 150; r is an integer between 1 and 3; s is an integer between 1 and 3; t is an integer between 0 and 3; u is an integer between 0 and 3; and X is selected from X 1 , X 2 , X 3 , X 4 and X 5 The groups consist of:

[0382]

[0383] The bold bonds represent bonds to [CH2] r and [CH2] s bonds to [CH2] t and [CH2] u ; and p is an integer between 1 and 5.

[0384] When considering the above structures, if two or more covalent bonds are connected in series, they should be interpreted together as one bond.

[0385] R 7 and R 8 It may be methyl, ethyl, isopropyl, n-propyl and / or tert-butyl.

[0386] Preferably, R 7 and R 8 It's methyl.

[0387] In one embodiment, R 7 and R 8 is a methyl group, and p and q are between 30 and 60.

[0388] In another embodiment, R 7 and R 8 is a methyl group, and p and q are between 50 and 70.

[0389] In yet another embodiment, r and s are 1.

[0390] In yet another embodiment, t and u are 1.

[0391] In one embodiment, R 7 and R 8 is methyl, p and q are between 30 and 60, and r and s are 1.

[0392] In another specific embodiment, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, and t and u are 1.

[0393] In yet another embodiment, R 7 and R 8 is methyl, p and q are between 30 and 60, r and s are 1, t and u are 1, and X is X 1 .

[0394] Synthesis of Diethylene Glycol Dienes

[0395] It has been found that alkylation of a di-ene-diol with an electrophilic pegylation agent is a suitable method for preparing di-pegylated dienes. In order to ensure complete conversion of the di-ene-diol to the di-pegylated diene and to minimize the formation of the intermediate mono-pegylated di-ene-diol, an excess of the pegylation agent is necessary. This results in a reaction mixture comprising multiple components that requires purification prior to hydrosilylation so that the di-pegylated diene can be used in the preparation of the coating precursor.

[0396] Specifically, it has been found that when a diene according to formula (III) is reacted with a pegylation agent according to formula (IV), the reaction is performed to synthesize a di-pegylated diene according to formula (II) above. The reaction mixture is suitable for purification by the method disclosed below:

[0397]

[0398] wherein r is an integer between 1 and 3; s is an integer between 1 and 3; t is an integer between 0 and 3; u is an integer between 0 and 3; and X is selected from X 1 , X 2 , X 3 , X 4 and X 5 The groups consist of:

[0399]

[0400] The bold bonds represent bonds to [CH2] r and [CH2] s bonds to [CH2]; non-bold bonds are those bonded to [CH2] t and [CH2] u a key; and p is an integer between 1 and 5;

[0401]

[0402] Among them, R 7 / 8 , that is, R 7 and R 8, independently selected from the group consisting of lower alkyl; p / q, i.e., p and q, independently are integers between 20 and 150; and L is a leaving group selected from the group consisting of chlorine, bromine, iodine, mesylate / ester, toluenesulfonate / ester and trifluoromethanesulfonate / ester;

[0403] In the specific diene according to formula (III), r and s are 1, t and u are 0, and X is X 1 .

[0404] In the specific diene according to formula (III), r and s are 1, t and u are 1, and X is X 1 .

[0405] In the specific diene according to formula (III), r and s are 1, t and u are 2, and X is X 1 .

[0406] In a specific diene according to formula (III), r and s are 1, t and u are 3, and X is X 1 .

[0407] In the specific diene according to formula (III), r and s are 1, t and u are 1, and X is X 4 , and p is 1.

[0408] In the specific diene according to formula (III), r and s are 1, t and u are 2, and X is X 4 , and p is 1.

[0409] In the specific diene according to formula (III), r and s are 1, t and u are 0, and X is X 4 , and p is 1.

[0410] In the pegylation agent according to formula (IV), R 7 / 8 Can independently be methyl or ethyl.

[0411] In the pegylation agent according to formula (IV), L may be a tosylate or a mesylate.

[0412] In the pegylation agent according to formula (IV), p and q may independently be integers between 30 and 60.

[0413] In the pegylation agent according to formula (IV), p and q are independently integers between 30 and 60, L is tosylate, and R 7 / 8 It's methyl.

[0414] The reaction mixture from the alkylation of a di-ene-diol according to formula (III) with more than two equivalents of a pegylation agent of formula (IV) generally comprises the di-pegylated diene of formula (II) in the form of a mixture with impurities. Examples of impurities are mono-pegylated di-ene-diol reaction intermediates; unreacted pegylation agent, R 7 / 8 -PEG-L; dimerization product of PEGylation reagent (R 7 / 8 -PEG)2O; Hydrolysis product of PEGylation reagent, R 7 / 8 -PEG-OH; and metal salts of HL and / or L - .

[0415] The reaction mixture may also include hydrophobic impurities such as solvent stabilizers and mineral oils used to protect reagents such as hydride bases used in the synthesis.

[0416] Fig. 9 Shown are examples of components of the reaction mixture of 2,2-diallyl-propane-1,3-diol with the di-PEGylated diene in the synthesis of compound 9 (Example 3a), the mPEG-OT alkylating agent, and the synthesis of compound 10 (Example 3b). Fig. 9 The n-decane in represents the mineral oil from the sodium hydride suspension used in the synthesis.

[0417] When analyzed by reverse phase HPLC, the PEGylated material was expressed as R 7 / 8 -PEG-OH<(R 7 / 8 -PEG)2O <R 7 / 8 -PEG-L The mono-PEGylated intermediate < di-PEGylated diene eluted in this order. Fig.10 A shows a reverse phase HPLC-ELSD chromatogram of the reaction mixture from the synthesis of compound 9 (Example 3a), showing mPEG (Tr (retention time) = 0.86 minutes), mPEG2O (Tr = 1.38 minutes), mPEG-OTs (Tr = 2.38 minutes), mono-PEGylated intermediates (Tr = 2.63 minutes) and di-PEGylated dienes (Tr = 3.68 minutes). According to HPLC-ELSD measurement, Fig.10 The purity of the reaction mixture in A was about 67%, area / area (a / a).

[0418] Purification of di-PEGylated dienes

[0419] The present application also relates to a method for purifying a di-PEGylated diene suitable for preparing a coating precursor by hydrosilylation as described above. The method has the advantage that a high purity di-PEGylated diene can be prepared without the use of expensive chromatography. The method also has the advantage that the method is suitable for a wide range of scales, for example from small laboratory scale to kilogram production scale and larger, compared to alternative methods that are only suitable for certain limited scales, thereby providing a clear advantage.

[0420] The method comprises the stepwise extraction of an impure aqueous solution of a di-PEGylated diene with an organic solvent at elevated temperature. During the extraction, the polarity of the aqueous phase is controlled by the addition of salt.

[0421] Surprisingly, impurities eluting in the middle of the reverse phase HPLC chromatogram can be selectively extracted from the aqueous phase prior to di-PEGylation of the diene, thereby allowing separation of the di-PEGylated diene from the impurities.

[0422] The method produces a high purity di-PEGylated diene, for example, 90% or more, or 95% or more, or 97% or more. When such a high purity di-PEGylated diene is used to synthesize a coating precursor, the resulting coating precursor can be of high purity.

[0423] Surprisingly, it has been discovered that under certain extraction conditions, the desired di-PEGylated diene can be selectively extracted from the reaction mixture by the stepwise extraction purification process disclosed herein. Specifically, impurities that elute close to but before the di-PEGylated diene in the reverse phase chromatogram can be selectively extracted from the aqueous solution containing the reaction product into the organic phase under these specific extraction conditions, leaving the di-PEGylated diene in the aqueous phase. Notably, this behavior is contrary to what would be expected from the elution order. The di-PEGylated diene can then be extracted from the aqueous phase, leaving the earlier eluting impurities in the aqueous phase.

[0424] In short, the step extraction includes two main parts - the intermediate extraction step (steps a) and b)) and the product extraction step (step c)).

[0425] In an intermediate extraction step, an aqueous solution of the impure di-PEGylated diene is treated with a salt to adjust the polarity of the solution (step a)), and the aqueous solution is repeatedly extracted with a primary organic extraction solvent at an elevated temperature (step b)). In this intermediate extraction, the presence of unreacted R 7 / 8 -PEG-L and any one or more mono-PEGylated di-ene-diol reaction intermediates are extracted into the organic phase, leaving an aqueous phase depleted of these impurities.

[0426] For the subsequent product extraction step (step c)), the amount of salt in the aqueous solution is increased and the solution is again repeatedly extracted with the primary extraction solvent at elevated temperature. In the product extraction, the di-PEGylated diene is extracted into the organic phase only together with small amounts of impurities.

[0427] The organic phase from the product extraction is concentrated (step d)) to obtain a residue (step e)). The residue obtained in step e) is dissolved in an aqueous buffer (step f)) and subjected to a refinement extraction (step g)) and then the organic phase from the refinement extraction is concentrated (step h) and step i)) before being used for the synthesis of the coating precursor.

[0428] Specifically, the method comprises the following steps:

[0429] a) providing an aqueous solution of an impure compound according to formula (II) as described above, wherein the aqueous solution comprises:

[0430] Water in an amount of 7.5 to 16.5 times the total mass of the impure compound according to formula (II) above; and NaCl in an amount of 6% to 9% (w / v) of the amount of water;

[0431] b) subjecting the aqueous solution of step a) to 2 to 5 intermediate extractions at a temperature between 40° C. and 70° C., wherein each intermediate extraction comprises the following steps:

[0432] b1) optionally; adding another portion of NaCl so that the total amount of NaCl added corresponds to less than step a)

[0433] The amount of NaCl is 9% (w / v) of the amount of water in the aqueous solution;

[0434] b2) extracting the aqueous solution with a carboxylate solvent; and

[0435] b3) removing the organic phase to provide an aqueous phase;

[0436] c) adding NaCl to the aqueous phase from step b3) in an amount of at least 1% of the amount of water in step a) so that the total amount of NaCl corresponds to an amount of NaCl of 8 to 12%, and subjecting the aqueous phase to 2 to 5 product extractions at a temperature of 40° C. to 70° C., wherein each product extraction comprises the following steps:

[0437] c1) extracting the aqueous phase with a carboxylic acid ester solvent; and

[0438] c2) removing the organic phase;

[0439] d) combining the organic phases from each step c2);

[0440] e) concentrating the combined organic phases from step d) to obtain a residue;

[0441] f) dissolving the residue from step e) in an aqueous buffer having a pH between 6 and 9 to provide an aqueous phase;

[0442] g) subjecting the aqueous phase from step f) to 2 to 4 polishing extractions, wherein each polishing extraction comprises the following steps:

[0443] g1) extracting the aqueous phase from step f) with a chlorinated solvent; and

[0444] g2) removing the organic phase;

[0445] h) combining the organic phases from each step g2); and

[0446] i) concentrating the combined organic phases from step h) to obtain a residue comprising the di-ethylene glycolated diene according to formula (II) above comprising less than 10% (w / w) impurities.

[0447] The aqueous solution in the intermediate extraction contains 7.5 to 16.5 parts of water per part of material including PEG (step a). If the aqueous solution is derived from a reaction mixture from the PEGylation of a diene, the total amount of material including PEG can be estimated as the sum of the masses of compounds including PEG introduced into the reaction mixture. Typically this is only the mass of R used in the reaction. 7 / 8 -The mass of PEG-L. Alternatively, the amount of material comprising PEG can be estimated based on the mass fraction of PEG in the material dissolved in the aqueous solution. The mass fraction of PEG can be estimated by many methods known to those skilled in the art, such as by quantitative 1 H-NMR.

[0448] The salt used to adjust the polarity of the aqueous phase is NaCl, and the concentrations given in this specification are for NaCl. However, the salt can be virtually any inorganic salt. Other salts such as KBr, LiCl, Na2SO4 or MgCl2 can be considered. If a salt other than NaCl is used to adjust the polarity of the aqueous solution, the relevant concentrations need to be recalibrated. Example 20 shows an example of how to recalibrate the salt concentration.

[0449] At the beginning of the intermediate extraction step, the amount of NaCl in the aqueous solution is between 6% and 9% (w / v) of the amount of water (step a)).

[0450] The aqueous phase in the intermediate extraction is extracted by using 2 to 5 parts of the primary extraction solvent at the initial salt concentration at a temperature of 40 to 70°C (step b)).

[0451] In one embodiment, the aqueous phase is first extracted with 2 to 5 parts of a primary extraction solvent, the primary extraction solvent being a carboxylic acid ester solvent (steps b2) and b3)), then the amount of salt in the aqueous phase is increased (step b1)) to a concentration that is higher than the starting concentration but still lower than 9% (w / v) of the amount of water in the aqueous solution of step a), and then the aqueous phase is extracted with an additional 2 to 5 parts of the primary extraction solvent (step b2)).

[0452] The primary extraction solvent is a carboxylic acid ester (ie, an alkyl ester of a carboxylic acid), such as ethyl acetate or isopropyl acetate.

[0453] Primary extraction solvents other than carboxylic acid esters may be considered, for example ketones, such as methyl ethyl ketone, methyl propyl ketone or diethyl ketone. Solvent mixtures having solvent properties similar to those of carboxylic acid esters may also be considered. Such solvent mixtures may include mixtures of aliphatic or aromatic hydrocarbons and chlorinated solvents.

[0454] The high temperature in the extraction of step b) is necessary both to achieve the desired selectivity in the extraction and to promote phase separation. At room temperature, the separation of the phases is impractically slow. At temperatures below 40° C., the extraction selectivity is unsatisfactory. It has been found that temperatures between 50° C. and 70° C., for example 60° C., are particularly suitable.

[0455] At the beginning of the product extraction step (step c)), the amount of NaCl in the aqueous solution is between 8% and 12% (w / v) of the amount of water.

[0456] In the product extraction (step c)), the aqueous phase is extracted 2 to 5 times.

[0457] The organic phases from the product extraction are combined (step d)) and concentrated (step e)), or concentrated before combining. Prior to concentration (step e), the organic phases may be subjected to a drying step. This can be achieved by many methods known to those skilled in the art, for example by drying with a desiccant, such as magnesium sulfate or using molecular sieves.

[0458] The residue obtained from the product extraction may include a certain amount of L - It may also include a certain amount of NaCl to adjust the polarity of the aqueous phase.

[0459] In step g), the residue from step e) is dissolved in an aqueous buffer (step f)) and then subjected to a polishing extraction step (step g)). In step f), the residue from the product extraction step is dissolved in a neutral or slightly alkaline aqueous buffer at a pH of 6 to 9. The aqueous solution is then extracted 2 to 4 times with a secondary extraction solvent, which is a chlorinated solvent (step g)).

[0460] In the polishing extraction step (step g)), the di-PEGylated diene is reacted with only a small amount of L - The salt or HL is extracted into the organic phase along with only a small amount of NaCl.

[0461] The secondary extraction solvent is a chlorinated organic solvent, such as dichloromethane, chloroform, tetrachloroethane or a chlorinated aromatic solvent. Dichloromethane can be used in particular as the secondary extraction solvent.

[0462] A suitable buffer for the polishing extraction step (step f)) is an aqueous sodium bicarbonate solution.

[0463] The organic phases from the polishing extraction are combined (step h)) and concentrated (step i)) to obtain a residue. Before removing the solvent, the organic phase is subjected to an additional drying step over a drying agent such as magnesium sulfate or using molecular sieves.

[0464] The residue obtained in step i) comprises di-PEGylated diene of high purity comprising less than 10% w / w of impurities. The amount of impurities can be measured by HPLC-ELSD.

[0465] Typically, the purity of the di-pegylated diene is 90% or more, such as 95% or more, such as 97% or more, such as 99% or more. Fig.10 A reverse phase HPLC-ELSD chromatogram of di-PEGylated diene 9 purified according to the present application is shown, indicating a purity of >99% (area / area).

[0466] The residue obtained after the finishing extraction can be subjected to hydrosilylation to produce the coating precursor according to the present application. The conditions for the hydrosilylation are known to those skilled in the art.

[0467] The aqueous solution provided in step a) can be obtained by evaporating the reaction solvent of the reaction mixture of the reaction between the di-ene-diol according to formula (III) and the pegylation agent according to formula (IV) and dissolving the obtained residue in water.

[0468] In view of the fact that the reaction solvent used for the synthesis of the di-pegylated diene is immiscible with water, it is usually more convenient to produce an aqueous solution for the intermediate extraction step (step b)) by primary extraction of the reaction mixture. In such a primary extraction, the reaction solvent and hydrophobic impurities are removed from the reaction mixture. In the primary extraction, the reaction mixture is treated with water and a salt to form a two-phase system, the organic phase is removed, and the aqueous phase, possibly after further addition of salt, is used as the aqueous solution provided in step a) and used for the intermediate extraction.

[0469] In one embodiment of the method, purification of the di-PEGylated diene starts with a quenched reaction mixture derived from reacting a di-ene-diol according to formula (III) and a PEGylating agent according to formula (IV) under alkaline conditions in a water-immiscible organic solvent and comprises four extraction steps - primary extraction 100, intermediate extraction 200, product extraction 300 and product purification 400. Figure 3 The overall process of this process including all four extraction steps is outlined. The details of the extraction steps are explained below.

[0470] The primary extraction 100, the intermediate extraction 200 and the product extraction step 300 are performed at a temperature between 50°C and 70°C, for example between 55°C and 65°C.

[0471] Figure 4 Overview of the primary extraction process 100. Using water and salt ( Figure 4 102) treating the reaction mixture ( Figure 4 101), forming a two-phase system ( Figure 4 103 in ).

[0472] The phases were mixed and allowed to separate by vigorous stirring ( Figure 4 104), forming a two-phase system again ( Figure 4 105 in). The organic phase contains most of the reaction solvent and almost all of the hydrophobic components of the reaction mixture. The hydrophobic components are usually limited to mineral oil, which comes from the use of a hydride base as a dispersion in mineral oil, but can include other undesirable non-polar compounds from any source. Removal of the organic phase ( Figure 4 106), and retain the aqueous phase ( Figure 4 107) for intermediate extraction ( Figure 4 108) in the further processing.

[0473] The process of intermediate extraction (steps a) and b)) can be as follows Figure 5 The primary extraction solvent (carboxylic acid ester solvent) is used to treat the primary extraction solvent (carboxylic acid ester solvent). Figure 5 201) of the aqueous phase, producing a two-phase system ( Figure 5 202), forming a two-phase system ( Figure 5 203 in). Remove the organic phase ( Figure 5 204 in ). Repeat the extraction process ( Figure 5 206) multiple times, so that step 204 is performed a total of 2 to 5 times.

[0474] Typically, the aqueous phase ( Figure 5 205) contains essentially no R 7 / 8-PEG-1 and mono-PEGylated di-ene-diol reaction intermediates After 3 to 4 extractions, the aqueous phase can be sent to product extraction ( Figure 5 214).

[0475] Alternatively, if an unsatisfactory amount of R remains in the aqueous phase 7 / 8 -PEG-1 and mono-PEGylated di-ene-diol reaction intermediates, more NaCl can be added ( Figure 5 Steps b1) and 207) in the above step, and the aqueous phase is repeatedly extracted ( Figure 5 208 to 213 in step 207). The amount of NaCl added in step 207 is such that the total amount of salt added in steps 102 and 207 is less than 9% (w / v) of the water added in step 102. The extraction process is repeated ( Figure 5 213) multiple times, so that step 211 is performed a total of 2 to 5 times.

[0476] Extract in the middle ( Figure 5 213) at the end of the aqueous phase substantially free of R 7 / 8 -PEG-L and mono-PEGylated di-ene-diol reaction intermediate. Intermediate extraction ( Figure 5 The aqueous phase at the end of the primary extraction (213) comprises most of the di-PEGylated diene product and most of the dimerization product of the PEGylation agent (R 7 / 8 -PEG)2O, and the hydrolysis product of the PEGylation reagent R 7 / 8 -PEG-OH.

[0477] The process of product extraction (step c) can be as follows Figure 6 As outlined in . With an additional portion of NaCl ( Figure 6 302) processing from the intermediate extraction ( Figure 6 The amount of NaCl added in step 302 is such that the total amount of salt added in steps 102, 207 and 302 is 8% to 12% (w / v) of the water added in step 102. The amount of NaCl added in step 302 is at least 1% (w / v) of the water added in step 102.

[0478] The aqueous phase is then treated with a portion of the primary extraction solvent (carboxylate solvent) Figure 6 303 in), and the phases were mixed and separated by vigorous stirring ( Figure 6 304 in), thus producing a two-phase system ( Figure 6 305 in). Take out the organic layer ( Figure 6 306 in). Product extraction ( Figure 6The organic phase in 309) includes the di-PEGylated diene product and some L - of salts or HL, and substantially no other PEGylated material.

[0479] For aqueous phase ( Figure 6 307) for further extraction ( Figure 6 308 in ), so that step 306 is performed 2 to 5 times in total.

[0480] The organic phase including the di-PEGylated diene product was concentrated ( Figure 6 310), resulting in a residue ( Figure 6 311 in). This is most conveniently achieved by distilling the solvent under reduced pressure. It is usually advantageous to dry the organic phase before concentration. This can be achieved by many methods known to those skilled in the art, for example by drying with a desiccant such as magnesium sulfate or using a molecular sieve.

[0481] You can Figure 7 Product purification was performed as outlined in . First, the residue from product extraction ( Figure 7 401) was dissolved in an aqueous buffer buffered to a pH between 6 and 9 ( Figure 7 402 in the.

[0482] Use secondary extraction solvent (chlorinated solvent) ( Figure 7 404) extracting the buffered aqueous solution ( Figure 7 403), resulting in a two-phase system ( Figure 7 405 in the above example).

[0483] Take out the organic phase ( Figure 7 406 in). Product purification ( Figure 7 The organic phase in 409) comprises a di-PEGylated diene product which is substantially free of low molecular weight impurities and substantially free of PEGylated impurities.

[0484] For aqueous phase ( Figure 7 407) for further extraction ( Figure 7 408 in ), so that step 406 is performed 2 to 4 times in total.

[0485] Combined from the refinement step ( Figure 7 409) and concentrated ( Figure 7 410 in). Advantageously, the organic phase is dried by a drying agent (such as magnesium sulfate) or using molecular sieves before removing the solvent.

[0486] The residue obtained by removing the solvent from the organic phase (i.e. after step i) Figure 7411) in includes a di-pegylated diene of sufficient purity so that when the di-pegylated diene is used to prepare a coating precursor according to the present application by hydrosilylation, the coating precursor requires only limited purification.

[0487] Typically, the purity of the di-pegylated diene is above 90%, such as above 95%, such as above 97%, such as above 99%. Fig.10 B shows the reverse phase HPLC-ELSD chromatogram of the purified di-PEGylated diene 9, indicating a purity of >99% (area / area).

[0488] In one embodiment, in the intermediate extraction step (step b)), the concentration of NaCl is between 7% and 8% (w / v); in the product extraction step (step c)), the concentration of NaCl is between 9% and 11% (w / v); the primary extraction solvent is ethyl acetate; the intermediate extraction and product extraction are carried out between 55°C and 65°C; and the secondary extraction solvent is dichloromethane.

[0489] Use of coating precursors for coating surfaces, especially nanostructured surfaces

[0490] The present application also relates to the use of the coating precursor according to the present application or the product of the above-mentioned method for coating a surface.

[0491] In particular, the coating precursors described herein can be used as intermediates in the preparation of coated nanostructures.

[0492] The surface can be the surface of an object ranging from macroscopic to microscopic to nanometer size. Typically, the surface is a nanostructured surface, and the product of the coating precursor coating the surface is a coated nanostructure. This coated nanostructure and its use are described below.

[0493] Preferably, the surface to be coated comprises silanol functional groups.

[0494] If the silanol functionality in the coating precursor includes alkoxy groups, the presence of some water may be beneficial for coating the surface.

[0495] If the surface to be coated is a nanostructured surface, dissolving the nanostructures in water or an aqueous mixture of solvents prior to contacting the surface with the coating precursor is a suitable method of coating the surface.

[0496] Suitably, the coating precursor is contacted with the surface to be coated by dissolving the coating precursor in a solvent, and the solution of the coating precursor is contacted with the solution of the nanostructures to be coated.

[0497] Suitable solvents for dissolving the coating precursor are aprotic polar organic solvents miscible with water, such as dioxane, THF (tetrahydrofuran), DMSO (dimethyl sulfoxide) or DMF (dimethylformamide).

[0498] If Z 1 and Z 2 R 1 , R 2 and R 3 are the same alkoxy, alcohol R 1 H is a suitable solvent for dissolving the coating precursor.

[0499] It is advantageous to use an anhydrous solvent to dissolve the coating precursor.

[0500] Advantageously, coating the surface with the coating precursor is carried out at an elevated temperature, such as above 60° C., such as above 80° C., such as above 100° C., such as above 120° C., such as above 140° C. Thus, preferably, coating is carried out at a temperature between 80° C. and 140° C., preferably between 100° C. and 120° C.

[0501] Advantageously, the solution of the coating precursor is slowly added to the surface to be coated, for example by adding multiple portions of the solution of the coating precursor. Alternatively, the solution of the coating precursor may be added to the surface to be coated by slowly injecting the solution of the coating precursor.

[0502] The coating precursor may be added to the surface to be coated in the form of a melt.

[0503] Alternatively, the coating precursor may be added in solid form to a solution of the nanostructures to be coated.

[0504] Specifically, a solution of the coating precursor may be slowly injected into a solution of the nanostructures to be coated.

[0505] In a preferred embodiment, a solution of the coating precursor in anhydrous THF or anhydrous dioxane is slowly injected into a solution of the nanostructures to be coated.

[0506] In a specific embodiment, Z of the coating precursor 1 and Z 2 R 1 , R 2 and R 3 is ethoxy, and a solution of the coating precursor in anhydrous ethanol is slowly injected into the solution of the nanostructures to be coated.

[0507] In a preferred embodiment, Z of the coating precursor 1 and Z 2 R 1 , R 2 and R3 is ethoxy, and a solution of the coating precursor in anhydrous ethanol is slowly injected into a solution of the nanostructures to be coated at a temperature between 100°C and 120°C.

[0508] In a particularly preferred embodiment, the coating precursor is 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane, the nanostructures to be coated include monomer residues derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane, dissolving the coating precursor in anhydrous ethanol or dioxane, dissolving the nanostructures to be coated in a solvent mixture including ethylene glycol and water, heating the solution of the nanostructures to be coated to between 100° C. and 120° C., and adding the coating precursor to the solution of the nanostructures to be coated by slow injection over a period of 10 to 50 hours, for example, 20 hours.

[0509] Example 14 illustrates the use of a coating precursor according to the present application for coating a nanostructure.

[0510] Examples 16a and 16b show that the nanostructures coated with the precursor according to the present application have a longer plasma half-life and better storage stability than the nanostructures coated with the reference precursor.

[0511] Nanostructures comprising a coating derived from a coating precursor

[0512] As described above, the coating precursor according to the present application can be used to prepare a coating on a nanostructure.

[0513] Therefore, the present application also relates to a spherical nanostructure comprising a coating derived from a coating precursor having a structure according to formula (I) as described above or from a product of a process according to the present application.

[0514] As described above, the coating precursor according to the present application includes reactive silane functional groups. This enables the coating precursor to form bonds with surfaces including functional groups capable of forming bonds of the structure GO-Si, where G represents atoms in the surface, such as silicon atoms, and Si represents silicon atoms from coating precursor molecules. In particular, nanostructures whose surfaces include silanol functional groups are suitable intermediates in the preparation of coated nanostructures according to the present application.

[0515] The nanostructures to be coated are also referred to as "precursor nanostructures".

[0516] The nanostructure to be coated with the coating precursor according to the present application can be referred to as a "hub". The hub generally comprises a polymer having reactive groups on the surface suitable for forming a bond with the coating precursor. Preferably, the hub comprises a cross-linked polymer network comprising siloxane connections. The reactive groups on the surface may include silanol groups.

[0517] The precursor nanostructure may have a simple structure comprising a single type of polymer, or a more complex structure comprising a composite of several different materials, such as multiple layers or regions of different materials, or consist of several substructures connected together, optionally arranged in layers.

[0518] The coated nanostructures include an outer layer, ie, a coating, which includes residues derived from a coating precursor.

[0519] Figure 2 An example of the structure of a coated nanostructure according to the present application is shown. The coated nanostructure includes three parts: 1) a nanostructure having a hydrodynamic diameter D A The center part, 2) thickness is [(D B -D A ) / 2], where D B is the hydrodynamic diameter of the central layer and the middle layer, and 3) the thickness is [(D C -D B ) / 2], where D C is the hydrodynamic diameter of the coated nanostructure.

[0520] The coated nanostructures may further include a radionuclide.

[0521] The coating precursor molecules are attached to the surface groups of the precursor nanostructures via siloxane bonds through the silane groups in the coating precursors. The coating is used to protect the central part of the nanostructure from aggregation and from interacting with proteins in living organisms, thereby enhancing the biocompatibility and stability of the coated nanostructures under physiological conditions.

[0522] Coated nanostructures in which the coating is derived from a coating precursor according to the present application have superior properties compared to coated nanostructures in which the coating is derived from certain other coating precursors. For example, compared to coated nanostructures in which the coating is derived from the structure mPEG-CH2-CH2-SiR 1 R 2 R 3 , where R 1 , R 2 and R 3is chlorine, bromine, iodine, lower alkoxy, aryloxy, carboxyl, amino or -NH-acyl), the coated nanostructure (wherein the coating is derived from the coating precursor according to the present application) shows higher storage stability (see Example 16).

[0523] Compared to coated nanostructures in which the coating is derived from certain other coating precursors, coated nanostructures in which the coating is derived from a coating precursor according to the present application exhibit superior in vivo performance. In Example 16a, it is shown that compared to coated nanostructures in which the coating is derived from 1-(ω-methyl-(ethyleneoxy) 45 Compared to similar nanostructures of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl)-3,5-bis(3-(triethoxysilyl)propoxy)-benzene (Compound 51, a compound outside the scope of the present invention), the coating was derived from 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane (Compound 10, a compound according to the present application) coated nanostructures exhibited a longer in vivo circulation time.

[0524] The coated nanostructures, wherein the coating is derived from the coating precursor according to the present application, show a high stability in terms of aggregation (see Example 16b).

[0525] In addition, the coated nanostructures, in which the coating is derived from a coating precursor according to the present application, show high stability in terms of the loss of coating residues derived from the nanostructures (see Example 16b). In Example 16b, it is shown that the nanostructures, in which the coating is derived from a coating precursor according to the present application, have better storage stability than nanostructures coated with a precursor outside the scope of the present application.

[0526] The coated nanostructures, wherein the coating is derived from the coating precursor according to the present application, have good solubility in water. In Example 21, it is shown that the solubility of the nanostructures coated with the coating according to the present application is at least 25% (w / v).

[0527] Specific embodiments of coated nanostructures

[0528] Preferably, the coated nanostructures may have a hydrodynamic diameter of between 10 nm and 100 nm, such as between 12 nm and 80 nm, such as between 14 nm and 60 nm, such as between 16 nm and 50 nm, such as between 18 nm and 45 nm, such as between 20 nm and 40 nm, such as between 25 nm and 35 nm.

[0529] In one embodiment, the coated nanostructures include a chelating group. Preferably, the chelating group is a bisphosphonate group, more preferably a geminal bisphosphonate group.

[0530] The coated nanostructures may further include a radionuclide.

[0531] In a specific embodiment, the coated nanostructure includes a central portion derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane.

[0532] In another specific embodiment, the coated nanostructure includes a central portion derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane and has a hydrodynamic diameter between 10nm and 100nm, such as between 12nm and 80nm, such as between 14nm and 60nm, such as between 16nm and 50nm, such as between 18nm and 45nm, such as between 20nm and 40nm, such as between 25nm and 35nm. Preferably, the hydrodynamic diameter is between 25nm and 35nm.

[0533] In another specific embodiment, the coated nanostructures have a hydrodynamic diameter between 25 nm and 35 nm, include a central portion derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane, and have a hydrodynamic diameter between 25 nm and 35 nm. 45 -methyl)-heptane coating.

[0534] In a preferred embodiment, the coated nanostructures have a hydrodynamic diameter between 25 nm and 35 nm and include a central portion derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane surrounded by an intermediate layer of a polymer derived from bis(triethoxysilyl)methane and a polymer derived from 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy)-heptane. 45 -methyl)-heptane outer coating.

[0535] Example 14 shows some examples of coated nanostructures with a coating derived from a coating precursor according to the present application.

[0536] Examples 16a and 16b demonstrate that nanostructures coated with the precursor according to the present application have a longer plasma half-life and better storage stability than nanostructures coated with the reference precursor.

[0537] Pharmaceutical compositions comprising coated nanostructures

[0538] The present application also relates to a pharmaceutical composition comprising a plurality of spherical nanostructures according to the present application.

[0539] The present application further relates to a pharmaceutical composition for cancer treatment or for imaging, wherein the pharmaceutical composition comprises a plurality of spherical nanostructures according to the present application, and wherein the nanostructures comprise a radionuclide.

[0540] The pharmaceutical composition has the advantage that the coating derived from the coating precursor according to the present application renders the components of the pharmaceutical composition highly biocompatible and / or bioinert.

[0541] The pharmaceutical composition can be used in medical imaging, such as medical imaging for cancer diagnosis.

[0542] The medical imaging may be, for example, SPECT or PET imaging.

[0543] When the pharmaceutical composition is used for medical imaging, the pharmaceutical composition further comprises a radioactive isotope (radionuclide).

[0544] The pharmaceutical composition according to the present application for SPECT imaging generally comprises gallium-67, indium-111, technetium-99m, lutetium-177 and / or thallium-201.

[0545] The pharmaceutical composition according to the present application for PET imaging generally comprises copper-62, gallium-68, rubidium-82, yttrium-86 and / or zirconium-89.

[0546] The pharmaceutical composition can be used to treat cancer, for example, by radionuclide therapy, in which case the coated nanostructure includes a radionuclide, such as actinium-225, copper-64, copper-67, holmium-166, lead-212, lutetium-177, radium-223, rhenium-186, rhenium-188, samarium-153, strontium-89, thorium-227, and / or yttrium-90.

[0547] In one embodiment, the radionuclide is 177 Lu, 153 Sm and / or 90 Y.

[0548] The pharmaceutical composition according to the present application exhibits desired pharmaceutical properties, such as a pharmacokinetic profile suitable for accumulation of the coated nanostructures in tumor tissues.

[0549] In Examples 17 and 18 the use of a pharmaceutical composition comprising coated nanostructures having a coating derived from a coating precursor according to the present application is shown.

[0550] Compared to the control group, mice with tumors treated with a pharmaceutical composition comprising a nanostructure according to the present application showed significantly increased mean and median survival times (see Example 17). In addition, tumor growth in the treatment group was significantly slowed (see Examples 17 and Fig.12 ).

[0551] Nanostructures as carriers of radionuclides

[0552] The present application also relates to the use of the spherical nanostructure according to the present application as a carrier of radioisotopes (radionuclide).

[0553] In this case, the nanostructure further comprises a chelating group. Preferably, the chelating group comprises a phosphonate, such as a geminal bisphosphonate.

[0554] As described above, carriers for radioisotopes can be used in cancer diagnosis (eg, medical imaging) and cancer therapy (see Examples 17 and 18), as described above.

[0555] In a preferred embodiment, the coated nanostructures include: a central portion including monomer residues derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane, and having monomer residues derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane coating.

[0556] In another preferred embodiment, the coated nanostructure comprises: (1) a core portion comprising monomer residues derived from 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane; (2) an intermediate layer derived from bis(triethoxysilyl)methane; and (3) a layer derived from 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane coating.

[0557] As described above, the carrier of the radioisotope may carry a radioisotope suitable for medical imaging, such as a radioisotope suitable for PET or a radioisotope suitable for SPECT, and / or a radioisotope suitable for radionuclide therapy.

[0558] Radioisotopes can be used, for example 177 Lu, 153 Sm and / or 90 Y.

[0559] Example

[0560] Examples of different implementations of the present application will be described below.

[0561] General experimental conditions

[0562] Unless otherwise stated, materials, reagents and solvents were obtained from commercial sources and used without further purification. If not otherwise stated, solvents were reagent grade or similar. Unless otherwise stated, reactions were carried out under N2.

[0563] MilliQ water refers to ultrapure water, such as water purified using a Millipore Milli-Q laboratory water system.

[0564] SIR-200 resin, a thiolated polystyrene resin was purchased from ResinTech, USA (resintech.com), activated by aqueous NaHCO3, washed carefully in EtOH and toluene, and used after azeotropic drying.

[0565] HPLC was performed on a Hewlett Packard series 1100 equipped with an Agilent Poroshell 120EC-C18 4.6×50 mm column, a DAD detector (diode array detector) recording at 220 nm and an ELSD detector (ELSD settings: 40° C., 1.4 L N2 / min, gain=4, impinger on) using a non-linear gradient starting from 43% acetonitrile in water at 1 mL / min, with an oven temperature of 40° C.

[0566] DLS was measured using a Malvern Instruments Zetasizer Nano ZEN3600 and processed using the general process settings in the Zetasizer software.

[0567] SEC was performed on a Younglin instrument YL9100 equipped with an Agilent Bio SEC-5 eluting at 1.2 mL / min at ambient temperature. Column, DAD detector recording at 220 nm, 280 nm and 560 nm and ELSD detector (ELSD settings: 60° C., 1.2 L N 2 / min, gain = 4).

[0568] In Varian Unity Inova 400MHz( 1 H at 399.95MHz, 13 NMR spectra were recorded on a 125.68 MHz (C) spectrometer using the residual solvent peak as 1 H NMR and 13 Internal standard for C NMR.

[0569] Compounds 31 (Tanikaga, R. et al., Synthesis, 1977, pp. 299-301), 50 (EP2572736), 51 (WO2018130713), and 52 (US2005255514) were synthesized according to literature procedures.

[0570] abbreviation

[0571] Tetrahydrofuran (THF), dichloromethane (DCM), dimethylformamide (DMF), ethyl acetate (EtOAc), methanol (MeOH), ethanol (EtOH), potassium acetate (KOAc), acetonitrile (MeCN), lithium aluminum hydride (LAH), methanesulfonyl chloride (MsCl), triethylamine (TEA), tris(hydroxymethyl)aminomethane (Tris), thin layer chromatography (TLC), m-PEG 45 -OTs (m-PEG45 tosylate), GF / A filter (glass microfiber filter, GF / A grade), saturated aqueous solution (sat.aq.), saline (saturated sodium chloride aqueous solution), polyethersulfone (PES), tangential flow filtration filter (TFF filter).

[0572] Example 1: Compound 5: 4-[ω-methyl-(ethyleneoxy) 45 Synthesis of 1,7-bis(triethoxysilyl)heptane

[0573]

[0574] Example 1a: Compound 2,4-ethoxycarbonyl-1,6-heptadiene

[0575] Diallylmalonate 1 was dissolved in DMSO (57 mL), then MilliQ water (650 μL) and LiCl (2.98 g, 70.5 mmol) were added. The reaction mixture was stirred for 3 hours at 190 ° C under nitrogen. The reaction was monitored by TLC until the starting material was fully converted. The solution was diluted with 100 mL of saline and extracted three times with 100 mL of ether. The combined organic phase was dried over anhydrous MgSO4, filtered, and evaporated in vacuo to obtain compound 2 (3.90 g, 72% yield) as a colorless oil.

[0576] 1 H NMR (400MHz, CDCl3) δ: 5.74 (m, J = 17.1, Hz, 2H), 5.04 (m, 4H), 4.13 (q, J = 7.1Hz, 2H), 2.50 (m, J = 8.0, 1H), 2.31 (m, 4H), 1.24 (t, J = 7.1Hz, 3H).

[0577] Example 1b: Compound 3,4-hydroxymethyl-1,6-heptadiene

[0578] In a 50mL reactor, under nitrogen, at 0°C, LiAlH4 was added to anhydrous THF (26.74mL). The mixture was cooled to -78°C and 4-ethoxycarbonyl-1,6-heptadiene 2 (2.34g, 139mmol) was added. After 1 hour, the mixture was allowed to reach room temperature. The reaction was monitored by TLC until the starting material was completely converted. The reaction mixture was cooled to 0°C, 225μL of MilliQ water was added in batches, followed by 225μL of 15% NaOH and 670μL of MilliQ water. Filtration and evaporation of volatiles gave the product 3 (1.272g, 72% yield) in the form of an oil purified by silica gel chromatography.

[0579] 1 H NMR (400MHz, CDCl3) δ: 5.82 (m, J = 17.2Hz, 2H), 5.05 (t, 4H), 3.57 (d, J = 5.6Hz, 2H), 2.12 (t, J = 6.1Hz, 4H), 1.72 (hept, J = 6.4Hz, 1H).

[0580] Example 1c: Compound 4,4-[ω-methyl-(ethyleneoxy) 45 -methyl]-1,6-heptadiene

[0581] In a 100 mL three-necked round-bottom flask, the diallyl alcohol 3 of Example 1b (262 mg, 1.23 mmol) was dissolved in anhydrous toluene (20 mL). The temperature of the reaction medium was set to 0°C, NaH (179.5 mg, 4.5 mmol, 60% dispersion in mineral oil) was added, and the mixture was stirred for 1 hour. m-PEG in toluene (25 mL) was added. 45 -OTs (5.84g, 2.7mmol) of azeotropic drying. The mixture was brought to room temperature within 1 hour and then heated to reflux. The reaction was monitored by TLC (heptane: ethyl acetate = 5: 1) and HPLC until complete conversion, then quenched by adding MilliQ water (330 μL) in batches at 60 ° C. Toluene was evaporated under vacuum, and the remaining solution was diluted with MilliQ water (78mL), then NaCl (4.1g) and EtOAc (25mL) were added. After vigorous stirring, the two layers were separated and the organic phase was removed. The remaining aqueous phase was extracted twice with EtOAc (50mL). The combined organic phase was dried with anhydrous MgSO4, filtered, and evaporated in vacuo to obtain white solid compound 4 (22% yield).

[0582] 1H NMR (400MHz, CDCl3) δ: 5.76 (m, 2H), 5.01 (m, 4H), 3.64 (s, 225H), 3.37 (s, 3H), 3.33 (d, J = 6.1Hz, 2H), 2.08 (m, 4H), 1.78 (m, 1H).

[0583] Example 1d: Compound 5,4-[ω-methyl-(ethyleneoxy) 45 -methyl]-1,7-bis(triethoxysilyl) Heptane

[0584] Triethoxysilane (205 μL, 0.182 g, 1.11 mmol, 4.0 equiv) was added to an azeotropically dried solution of compound 4 from Example 1c (595 mg, 0.27 mmol) in dry toluene (7 mL). The bath temperature was set to 30°C and Karstedt's catalyst (20.4 μL, 2% in xylene) was added. The reaction mixture was stirred at room temperature overnight. 1 H-NMR monitors the disappearance of olefin protons in the reaction. The solvent is then evaporated and excess silane is removed by coevaporation with anhydrous toluene (4 mL). The product is dissolved in toluene (5 mL), degassed with 3 vacuum / nitrogen cycles, and stirred at 60° C. for 4 days with activated SIR-200 resin (1.56 g). Filtration and evaporation of the solvent affords 217.9 mg (36.2% yield) of compound 5 as a colorless solid.

[0585] 1 H NMR (400MHz, CDCl3) δ: 3.72 (q, J=7.0Hz, 2H), 3.64 (s, 191H), 3.38 (s, 2H), 1.24 (m, 3H).

[0586] Example 2: Compound 8, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 17 Synthesis of -methyl)-heptane

[0587]

[0588] Example 2a: Compound 6, 2,2-diallyl-1,3-propanediol

[0589] At 0 ° C, diethyl diallylmalonate 1 (245g, 1mmol) was added dropwise to a suspension of LiAlH4 (94.93g, 2.37mmol, 2.4 equivalents) in anhydrous THF (1000mL). The addition rate was adjusted so that the internal temperature was kept below 10 ° C. The reaction was stirred at room temperature overnight. The reaction was confirmed to be complete by TLC (heptane: EtOAc = 7: 3, Rf (SM) 0.6, Rf (product) 0.2, color development with KMnO4). The reaction mixture was cooled to -5 ° C and quenched by slowly adding H2O (100mL) in batches over 4.5 hours, followed by slowly adding 15% (w / v) NaOH aqueous solution (100mL) and 282mL of H2O in batches and stirring overnight at 20 ° C. The suspension was filtered through two GF / A filter papers and the filter cake was washed three times with 300mL THF. The volatiles were evaporated under reduced pressure to afford the desired product 6 (158.7 g, >99% yield) as a yellow oil.

[0590] 1 H NMR (400MHz, CDCl3) δ: 5.83 (m, 2H), 5.11 (m, 4H), 3.56 (s, 4H), 2.07 (d, 4H).

[0591] Example 2b: Compound 7, 4,4-bis(ω-methyl-(ethyleneoxy) 17 -methyl)-heptadiene

[0592] Compound 6 from Example 2a (178 mg, 1.13 mmol) was dissolved in anhydrous toluene (15 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (199 mg, 7.9 mmol, 95% (w / w) in mineral oil, 7 equiv.) was added in portions. The mixture was then stirred at room temperature for 30 minutes, and azeotropically dried m-PEG was added under N2 at 0°C. 17-OTs (4.44g, 4.74mmol, 4.2 equivalents) in toluene (25mL) solution. The reaction mixture was heated to reflux overnight. The reaction was monitored by HPLC, and the temperature was lowered to 15 ° C after completion, and the reaction was quenched by slowly adding H2O (1mL). The pH of the crude product was adjusted to between pH 5 and 7 with 1.0MHCl, and the mixture was diluted with H2O (60mL). NaCl (4.5g) was added at 60 ° C, and the reaction mixture was extracted three times with EtOAc (20mL). NaCl (1.5g) was added to the remaining aqueous phase, and the mixture was additionally extracted with EtOAc (20mL) at 60 ° C. The extracted fractions with acceptable product purity were combined, and the solvent was evaporated. The obtained residue was purified by flash chromatography (C18 column, H2O: acetonitrile, 60: 40) and dissolved in DCM. The mixture was then dried over MgSO4, filtered and evaporated to give the desired product 7 (892 mg, 46% yield).

[0593] 1 H NMR (400MHz, CDCl3) δ5.79(m,2H),5.04(m,4H),3.65(s,350H),3.38(s,6H),3.23(s,2H),2.05(d,2H).

[0594] Example 2c: Compound 8, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 17 -First 4-(2-(4-(2-methyl-1-oxo-2-yl)-heptane

[0595] Triethoxysilane (3.97 g, 21 mmol, 40 equiv) was added to an azeotropically dried solution of compound 7 from Example 2b (0.88 g, 0.528 mmol) in toluene (7 mL). The bath temperature was set to 30° C. and Karstedt's catalyst (77 μL, 2% (w / w) in xylene) was added. The reaction mixture was stirred at room temperature overnight.

[0596] pass 1 H-NMR monitored the disappearance of olefin protons in the reaction. The solvent was subsequently evaporated and excess silane was removed by coevaporation with anhydrous toluene (10 mL). The product was dissolved in toluene (17 mL), degassed with 3 vacuum / nitrogen cycles, and stirred with activated SIR-200 resin (710 mg) at 60° C. for 4 days. The solution was filtered from the resin, the resin was washed with toluene (3×12 mL), and the solvent was evaporated in vacuo to produce compound 8 (876 mg, 82.4% yield) in the form of a colorless solid.

[0597] 1H NMR (400MHz, CDCl3) δ: 3.71-3.60 (d, 123H), 3.56 (m, 4H), 3.39 (s, 6H), 1.26 (d, J = 2.8Hz, 5H).

[0598] Example 3: Compound 10: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 Synthesis of -methyl)-heptane

[0599]

[0600] Example 3a: Compound 9, 4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptadiene

[0601] Diallyl propanediol 6 (22 g, 0.1411 mol) was dissolved in anhydrous toluene (2.61 L) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (23.7 g, 0.593 mol, 60% (w / w) in mineral oil, 4.2 equiv) was added in three portions, keeping the temperature below 10°C. The slurry was then stirred at room temperature for 60 minutes and then added to the m-PEG 1000 solution under N2 at 0°C. 45 -OTs (1.071kg, 0.9877mmol, 3.5 equivalents) in anhydrous toluene (2.61L) in an azeotropic dried solution. The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC, and the temperature was lowered to 15°C after completion, and the reaction was quenched by adding H2O (70mL) dropwise. The pH of the crude reaction mixture was adjusted to 5 to 7 with 1.0M HCl (100mL). For practical reasons, the crude reaction mixture was divided into two identical parts, and the two parts were extracted independently. Each half of the crude mixture was diluted with H2O (7.14L). The temperature was raised to 60°C, and NaCl (540g) was added. The mixture was then stirred for 45 minutes and extracted three times with EtOAc (2.1L). NaCl (200g) was added to the remaining aqueous phase, and the mixture was extracted three times with EtOAc (2.1L) again. The last three extracted fractions had acceptable product purity (HPLC) and were dried over MgSO, filtered through a double GF / A filter and the solvent evaporated. The resulting residues were combined and dissolved in H2O (2.0 L) and the pH was adjusted to pH 8 with a 0.8 M aqueous NaHCO3 solution (100 mL). The aqueous phase was extracted three times with DCM (500 mL). The organic phase was dried over MgSO4, filtered and evaporated to give a white residue.

[0602] The extraction process was repeated on the other half of the crude mixture and the final products of the two extractions were combined to obtain the desired compound 9 (758 g, 66.36% yield, 96.8% purity (HPLC-ELSD)).

[0603] 1 H NMR (400MHz, CDCl3) δ5.80(m,2H),5.03(m,4H),3.81(m,4H),3.70-3.60(s,540H),3.37(s,6H),3.22(s,4H),2.04(d,4H).

[0604] Example 3b: Compound 10, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 - Methyl)-heptane

[0605] Triethoxysilane (1117 g, 6.88 mol, 40 equiv) was added to an azeotropically dried solution of compound 9 from Example 3a (714 g, 0.172 mol) in toluene (5.5 L) at 22° C. under nitrogen. Karstedt's catalyst (25.34 mL, 2% (w / w) in xylene, 1.14 mmol, 0.0066 equiv) was added in 1 mL portions using a syringe over 30 minutes, which resulted in an exotherm of ≤ 2° C. The reaction mixture was stirred at 22° C. under nitrogen overnight.

[0606] pass 1 H-NMR monitored the disappearance of olefin protons in the reaction. The solvent was subsequently evaporated and excess silane was removed by coevaporation with anhydrous toluene (2.5 L) four times in total. The residue was redissolved in toluene (4.2 L), degassed with 3 vacuum / nitrogen cycles, and stirred with activated SIR-200 resin (175 g) at 60 ° C for 3 days. The solution was filtered from the resin, the resin was washed with toluene (3×2.8 L), and the collected fractions were filtered and combined through a double GF / A filter. The solvent was evaporated to obtain compound 10 in the form of a white solid in quantitative yield (783.2 g, ≥99%, purity 94.4% (HPLC-ELSD)).

[0607] 1 H NMR (400MHz, C6D6) δ3.88(q,12H),3.70-3.40(s,400H),3.14(s,6H),1.68(m,4H),1.59(m,4H),1.23(t,18H),0.79(t,4H).

[0608] Example 4: Compound 12: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 67 Synthesis of -methyl)-heptane

[0609]

[0610] Example 4a: Compound 11,4,4-bis(ω-methyl-(ethyleneoxy) 67 -methyl)-heptadiene

[0611] Diallyl propanediol 6 (1.14 g, 7.14 mmol) was dissolved in anhydrous toluene (195 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (717 mg, 17.9 mmol, 60% (w / w) in mineral oil, 2.5 eq.) was added in three portions, keeping the temperature below 10°C. The slurry was stirred at room temperature for 60 minutes, and then m-PEG was added under N2 at 0°C. 67 -OTs (80g, 25mmol, 3.5 equivalents) in an azeotropically dried solution of anhydrous toluene (195mL). The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC, and the temperature was lowered to 15°C after completion, and the reaction was quenched by dropwise addition of H2O (3mL). The pH of the crude product was adjusted to pH 5 to 7 with 1.0M HCl (6.5mL). The reaction mixture was diluted with H2O (533mL), the temperature was raised to 60°C, and NaCl (80mg) was added. The mixture was stirred for 45 minutes and extracted three times with EtOAc (300mL). NaCl (16g) was added to the remaining aqueous phase, and the mixture was additionally extracted three times with EtOAc (300mL). The fourth and fifth extracted fractions had acceptable product purity (HPLC), and were dried with MgSO4, filtered through a double GF / A filter, and the solvent was evaporated. The residue was dissolved in H2O (500 mL) and the pH was adjusted to pH 8 with 0.8 M NaHCO3 aqueous solution (30 mL). The aqueous phase was extracted three times with DCM (100 mL). The organic phase was dried over MgSO4, filtered and evaporated to give the desired compound 11 (11.1 g, 49.0% yield, 98.3% purity (HPLC-ELSD)).

[0612] 1 H NMR (400MHz, CDCl3) δ5.77(m,2H),5.02(m,4H),3.81(m,4H),3.70-3.60(s,875H),3.37(s,6H),3.22(s,4H),2.04(d,4H).

[0613] Example 4b: Compound 12, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 67 - Methyl)-heptane

[0614] Triethoxysilane (10.4 g, 64 mmol, 40 equiv) was added to an azeotropically dried solution of compound 11 from Example 4a (10 g, 1.6 mmol) in toluene (77.5 mL) at 22° C. under nitrogen. Karstedt's catalyst (235.6 μL, 2% (w / w) in xylene, 0.023 mmol, 0.0066 equiv) was then added over 30 minutes using a syringe, which resulted in an exotherm of ≤ 2° C. The reaction mixture was stirred at 22° C. under nitrogen overnight.

[0615] pass 1 H-NMR monitored the disappearance of olefin protons in the reaction. The solvent was subsequently evaporated and excess silane was removed by coevaporation with anhydrous toluene (39 mL) four times in total. The residue was redissolved in toluene (59 mL), degassed with 3 cycles of vacuum / nitrogen, and stirred with activated SIR-200 resin (1.65 g) at 60 ° C for 3 days. The mixture was filtered through two GF / A filters and the remaining SIR-200 resin was additionally stirred in anhydrous toluene (39 mL) to recover the product. This step was repeated three times in total. The collected fractions were filtered through two GF / A filters, combined, and the solvent was evaporated to obtain the desired product 12 (11.22 g, ≥99% yield, 78.3% purity (HPLC-ELSD)) in quantitative yield.

[0616] 1 H NMR (400MHz, C6D6) δ3.88(q,12H),3.60-3.40(s,583H),3.14(s,6H),1.67(m,4H),1.57(m,4H),1.23(m,18H),0.79(t,4H).

[0617] Example 5: Compound 14: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 90 Synthesis of -methyl)-heptane

[0618]

[0619] Example 5a: Compound 13, 4,4-bis(ω-methyl-(ethyleneoxy) 90 -methyl)-heptadiene

[0620] Diallyl propanediol 6 (176.2 mg, 1.102 mmol) was dissolved in anhydrous toluene (42 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (185.2 mg, 4.628 mmol, 60% (w / w) in mineral oil, 4.2 equiv) was added in three portions, keeping the temperature below 10°C. The slurry was stirred at room temperature for 60 minutes, and then added to the m-PEG under N2 at 0°C. 90-OTs (17 g, 3.86 mmol, 3.5 eq) in an azeotropically dried solution of anhydrous toluene (42 mL). The reaction mixture was heated to reflux overnight and stirred under N2.

[0621] The next day, additional NaH (22 mg, 0.917 mmol, 0.5 eq) was added and the mixture was stirred at reflux for 4 h. Crushed NaOH (50 mg) was added to the mixture and stirring was continued at reflux overnight under N2.

[0622] The reaction was monitored by HPLC, and the temperature was lowered to 15°C after completion, and the reaction was quenched by dropwise addition of H2O (1mL). The pH of the crude product was adjusted to pH 5 to 7 with 1.0M HCl (2.7mL). The reaction mixture was diluted with H2O (113mL), the temperature was raised to 60°C, and NaCl (17g) was added. The mixture was stirred for 45 minutes and extracted three times with EtOAc (60mL). NaCl (6g) was added to the remaining aqueous phase, and the mixture was additionally extracted three times with EtOAc (60mL). The final extraction fraction had an acceptable product purity (HPLC), and was dried with MgSO4, filtered through a double GF / A filter, and the solvent was evaporated. The resulting residue was dissolved in H2O (30mL), and the pH was adjusted to pH 8 with 0.8M NaHCO3 aqueous solution (10mL). The aqueous phase was extracted three times with DCM (11mL). The organic phase was dried over MgSO4, filtered and evaporated to give the desired compound 13 (3.2 g, ≥35.6% yield, 83% purity (HPLC-ELSD)).

[0623] 1 H NMR (400MHz, CDCl3) δ5.80(m,2H),5.02(m,4H),3.81(m,4H),3.70-3.60(s,875H),3.38(s,6H),3.23(s,4H),2.05(d,4H).

[0624] Example 5b: Compound 14, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 90 - Methyl)-heptane

[0625] Triethoxysilane (1.75 g, 10.88 mmol, 40 equiv) was added to an azeotropically dried solution of compound 13 from Example 5a (3 g, 0.272 mmol) in toluene (23.25 mL) at 22° C. under nitrogen. Karstedt's catalyst (40.06 μL, 2% (w / w) in xylene, 0.00386 mmol, 0.0066 equiv) was then added over 30 minutes using a syringe, which resulted in an exotherm of ≤ 2° C. The reaction mixture was stirred overnight at 22° C. under nitrogen.

[0626] pass 1 The olefin proton disappears in the H-NMR monitoring reaction. The solvent is subsequently evaporated and the excess silane is removed by coevaporation with anhydrous toluene (11.7 mL) four times in total. The residue is redissolved in toluene (17.7 mL), degassed with 3 cycles of vacuum / nitrogen, and stirred at 60 ° C for 3 days with activated SIR-200 resin (300 mg). The mixture is then filtered through two GF / A filters, and the remaining SIR-200 resin is additionally stirred in anhydrous toluene (11.7 mL) to reclaim the product. This step was repeated three times in total. The collected fractions are filtered through two GF / A filters, merged, and the solvent is evaporated to obtain the desired product 14 (2.73 mg, ≥32.1% yield, 27.1% purity (HPLC-ELSD)) in the form of a white solid.

[0627] 1 H NMR (400MHz, C6D6) δ3.94(q,12H),3.60-3.40(s,752H),3.14(s,6H),1.22(m,18H).

[0628] Example 6 (prophetic example): Compound 16: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 112 -Methyl)-heptane synthesis:

[0629]

[0630] Example 6a (prophetic example): Compound 15, 4,4-bis(ω-methyl-(ethyleneoxy) 112 -methyl)-heptyl-1, 6-Diene

[0631] Before starting the reaction, water is removed from the starting material using a Dean-Stark apparatus. The two alcohol groups of compound 6 are deprotonated with a strong base (such as NaH) and reacted with a PEGylation reagent carrying a suitable leaving group (such as m-PEG 112 -OTs) was coupled with an azeotropically dried solution of to afford compound 15.

[0632] Example 6b (prophetic example): Compound 16, 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl- (ethyleneoxy) 112 -methyl)-heptane

[0633] Before starting the reaction, water is removed from the starting material using a Dean-Stark apparatus. The two allyl groups of compound 15 are hydrosilylated using a silane such as (EtO)3SiH and a catalyst such as a platinum compound such as Karstedt's catalyst. Optionally, any residual platinum is removed by treatment with activated SIR-200 resin to obtain final compound 16.

[0634] Example 7: Compound 21: 1,7-bis(triethoxysilyl)-4-(2,2-bis(ω-methyl-(ethyleneoxy) 45 Synthesis of -methyl)-ethyl)-heptane

[0635]

[0636] Example 7a: Compound 17, 2-allylpent-4-enyl methanesulfonate

[0637] In a 100mL round-bottom flask, diallyl alcohol 3 (1.00g, 7.92mmol) was dissolved in DCM (40mL). The reaction temperature was set to 0°C, and triethylamine (1.1mL, 11.9mmol, 1.5 equivalents) was added. After stirring for 30 minutes, MsCl (0.914, 9.5mmol, 1.2 equivalents) was added in batches. The mixture was allowed to reach room temperature and stirred for an additional 3 hours. The reaction was monitored by TLC until the starting material was fully converted and quenched by adding 0.5M HCl (36mL). The two layers were separated and the organic phase was removed. The aqueous phase was extracted three times with DCM (36mL). The combined organic phase was dried over anhydrous MgSO4, filtered, and evaporated in vacuo to obtain compound 17 (1.387g, 85.7% yield) in the form of a colorless oil.

[0638] 1 H NMR (400MHz, CDCl3) δ: 5.76 (m, 2H), 5.09 (d, 4H), 4.13 (d, J = 5.6Hz, 2H), 3.00 (s, 3H), 2.16 (t, J = 7.0Hz, 4H), 1.93 (hept, J = 6.4Hz, 1H).

[0639] Example 7b: Compound 18, (2-allyl-pent-4-enyl)-malonic acid diethyl ester

[0640] NaH (48.6mg, 1.17mmol, 60% (w / w) dispersion in mineral oil) is suspended in dry DMF (1.7mL) and THF (850 μL), and is cooled to 0 ℃. Diethyl malonate 1 (187mg, 1.17mmol) is added dropwise, and the reaction is warmed to room temperature. A solution of the crude product (80mg, 0.392mmol) from Example 7a in anhydrous THF (850 μL) is added, followed by KI (167mg, 1.17mmol). The reaction mixture is stirred overnight at 80 ℃, reflux and under nitrogen. The reaction is monitored by TLC until complete conversion and allowed to cool at room temperature. Quenched with saturated NH4Cl (3mL), and extracted with EtOAc (3×2mL). Combine organic phases, dry through MgSO4, filter, and remove solvent under vacuum. The resulting residue was purified by short flash chromatography (heptane:EtOAc=7:1) to afford the desired compound 18 in quantitative yield as a yellow oil.

[0641] 1 H NMR (400MHz, CDCl3) δ: 5.74 (m, 2H), 5.04 (m, 4H), 4.19 (m, J = 7.1, 4H), 3.46 (t, J = 7.7Hz ,1H),2.07(m,4H),1.87(t,J=7.3Hz,2H),1.54(m,J=13.0,1H),1.26(t,J=7.1Hz,6H).

[0642] Example 7c: Compound 19, (2-(2-allyl-pent-4-enyl)-diethyl-1,3-propanediol

[0643] At 0°C, a solution of compound 18 (247 mg, 0.92 mmol) from Example 7b in THF (1.5 mL) was added dropwise to a suspension of LiAlH4 (88.24 mg, 2.4 equivalents) in THF (3 mL), keeping the exotherm below 5°C during the addition. The reaction was allowed to reach room temperature and stirred for 6 hours. The reaction was monitored by TLC until complete conversion. The temperature was lowered to 0°C, and the reaction was quenched by adding H2O (1.0 mL), followed by 15% NaOH (0.2 mL), and then diluted with 1 mL of H2O. A white precipitate was observed, and the suspension was filtered through two GF / A filters, and the filter cake was washed with 2 mL of THF. Volatiles were removed under vacuum, and the resulting residue was purified by flash chromatography (heptane: EtOAc = 3: 2, then heptane: EtOAc = 1: 1) to obtain the desired product 19 (114 mg, 67.4% yield).

[0644] 1H NMR (400MHz, CDCl3) δ: 5.83-5.68 (m, 2H), 5.02 (d, 4H), 3.80 (dd, J = 10.6, 3.7Hz, 2H), 3.63 (dd, J = 10.6, 7.6Hz, 3H), 2.14-1.98 (m, 4H), 1.96-1.85 (m, 1H), 1.57 (dq, J = 12.9, 6.5Hz, 1H), 1.16 (t, J = 7.0Hz, 2H).

[0645] Example 7d: Compound 20, 2-(2-allyl-pent-4-enyl)-diethyl-1,3-bis(ω-methyl-(ethylene Oxy) 45 -methyl)-propane

[0646] Compound 19 from Example 7c (110 mg, 0.6 mmol) was dissolved in anhydrous toluene (15 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (111 mg, 4.2 mmol, 90% (w / w) in mineral oil, 7 equiv.) was added in portions. The mixture was then stirred at room temperature for 30 minutes, and m-PEG was added under N2 at 0°C. 45 -OTs (5.43g) in toluene (25mL) through azeotropic drying solution. The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC, and the temperature was lowered to 15°C after completion, and the reaction was quenched by slowly adding H2O (0.3mL). The solvent was evaporated and the residue was dissolved in H2O (72mL). NaCl (5.42g) was added at 60°C and the reaction mixture was extracted once with EtOAc (25mL). NaCl (1.80g) was added to the remaining aqueous phase, and the mixture was additionally extracted with EtOAc (25mL) at 60°C. The organic phases were combined, dried over MgSO4, filtered and the solvent was evaporated. The resulting residue was purified by flash chromatography (C18 column, H2O: acetonitrile = 63: 47) to obtain the desired product 20 (485mg, 19% yield).

[0647] 1 H NMR (400MHz, CDCl3) δ5.74(m,2H),5.00(m,4H),3.71-3.60(s,225H),3.39(m,6H),2.20(m,4H),1.25(s,4H).

[0648] Example 7d: Compound 21, 1,7-bis(triethoxysilyl)-4-(2,2-bis(ω-methyl-(ethyleneoxy) base) 45 -methyl)-ethyl)-heptane

[0649] Triethoxysilane (0.22 g, 1.3 mmol, 40 equiv) was added to an azeotropically dried solution of compound 20 from Example 7d (0.13 g, 0.035 mmol) in dry toluene (2 mL). The bath temperature was set to 30 °C and Karstedt's catalyst (5 μL, 2% (w / w) in xylene) was added. The reaction mixture was stirred at room temperature overnight. 1 H-NMR monitored the disappearance of olefin protons in the reaction. The solvent was subsequently evaporated and excess silane was removed by coevaporation with anhydrous toluene (2 mL). The product was dissolved in toluene (2 mL), degassed with 3 vacuum / nitrogen cycles, and stirred with activated SIR-200 resin (50 mg) at 60 ° C for 2 days. Filtering and evaporating the solvent gave the final compound 21 in the form of a colorless solid.

[0650] Example 8: Compound 34: 1,9-bis(triethoxysilyl)-5,5-bis(ω-methyl-(ethyleneoxy) 45 Synthesis of -methyl)-nonane

[0651]

[0652] Example 8a: Compound 23, 2,2-di-but-3-enyl-malonic acid diethyl ester

[0653] In a 100mL round-bottom flask, NaH (2.4g, 0.1mol, 60% (w / w) dispersion in mineral oil) was suspended in 50mL dry DMF at 0°C under nitrogen. At 0°C, dimethyl malonate 22 (2.3mL, 0.02mmol) was added to the mixture, followed by 4-bromo-1-butene (5.20mL, 0.052mmol, 2.6 equivalents). The suspension was stirred at room temperature for 2 hours, then gradually heated to 70°C and stirred overnight. The next day, the reaction was cooled to room temperature and quenched with NH4Cl (50mL, sat.aq.). The reaction mixture was extracted three times with 100mL ether. The organic phases were combined, dried over MgSO4, filtered, and the solvent was removed under vacuum. The resulting residue was flash chromatographed (heptane: EtOAc = 9: 1) to obtain the desired product 23 (4.06g, 84.7% yield) in the form of a yellow oil.

[0654] 1 H NMR (400MHz, CDCl3) δ: 5.77 (m, 2H), 5.00 (m, 4H), 3.72 (s, 6H), 1.98 (m, 8H).

[0655] Example 8b: Compound 24, 2,2-di(but-3-enyl)propane-1,3-diol

[0656] At 0°C, a solution of compound 23 (3.59 g, 0.015 mmol) from Example 8a in THF (15 mL) was added dropwise to a suspension of LiAlH in THF (30 mL), keeping the exotherm below 5°C during the addition. The reaction was stirred at room temperature overnight and monitored by TLC until complete conversion. The reaction was quenched by adding H2O (4.0 mL), then 15% (w / v) NaOH (4.0 mL), and finally 20 mL of H2O. A white precipitate was observed, and the suspension was filtered through two GF / A filters, and the filter cake was washed twice with 20 mL of THF. The suspension was extracted three times with DCM (50 mL). The combined organic phase was washed with brine (150 mL), dried over MgSO4, filtered, and the solvent was removed under vacuum. The resulting residue was flash chromatographed (heptane: EtOAc = 7: 3) to obtain the desired product 24 (2.0 g, 70% yield).

[0657] 1 H NMR (400MHz, CDCl3) δ: 5.82 (m, J = 16.8Hz, 2H), 5.04 (d, J = 17.26Hz, 2H), 4.96 (d, J = 10.15Hz, 2H), 3.60 (s, 4H), 2.01 (m, 4H), 1.40 (m, 4H).

[0658] Example 8c: Compound 25, 5,5-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-nona-1,8-diene

[0659] NaH (272 mg, 10.8 mmol, 95% in mineral oil, 2.9 equiv), compound 24 from Example 8b (1.0 g, 3.73 mmol) and m-PEG 45 A mixture of -OTs (19.41 g, 8.9 mmol, 2.4 equiv) in 100 mL of anhydrous THF was heated to 40 °C and stirred overnight under N2. The reaction was monitored by TLC and quenched by slowly adding H2O (5 mL) after completion. The reaction mixture was dried over MgSO4, filtered, and the solvent evaporated to obtain a white residue. In order to remove impurities from the residue, the crude product was first dissolved in DCM (50 mL) and then precipitated by adding ether (200 mL). The white solid was filtered out and the precipitation process was repeated three times to obtain the desired product 25.

[0660] 1 H NMR (400MHz, CDCl3) δ: 5.80 (m, 2H), 4.98 (m, 4H), 3.70-3.60 (s, 659H), 3.54 (m, 4H), 3.37 (s, 6H), 2.03 (s, 4H), 1.36 (m, 4H).

[0661] Example 8d: Compound 26, 1,9-bis(triethoxysilyl)-5,5-bis(ω-methyl-(ethyleneoxy) 45 - Methyl)-nonane

[0662] Triethoxysilane (550 μL, 2.94 mmol, 4.0 equiv) was added to an azeotropically dried solution of compound 25 from Example 8c (3.0 g, 0.724 mmol) in anhydrous toluene (25 mL). The bath temperature was set to 30°C and Karstedt's catalyst (100 μL, 2% (w / w) in xylene) was added. The reaction mixture was stirred at room temperature overnight. 1 The olefin proton disappears in the H-NMR monitoring reaction. The solvent is subsequently evaporated and excess silane is removed by coevaporation with anhydrous toluene (40 mL). The product is dissolved in toluene (50 mL), degassed with 3 vacuum / nitrogen cycles, and stirred 4 days at 60 ℃ with activated SIR-200 resin (2.28 g). After filtering and washing three times with toluene (50 mL), the solvent is evaporated and compound 26 (2.419 g, 75.6% yield) is obtained as a colorless solid.

[0663] 1 H NMR (400MHz, CDCl3) δ: 3.88-3.73 (m, 12H), 3.62 (s, 365H), 3.52 (m, 4H), 3.35 (s, 6H), 1.20 (q, J = 6.9Hz, 18H).

[0664] Example 9: Compound 30: 1,11-bis(triethoxysilyl)-6,6-bis(ω-methyl-(ethyleneoxy) 45 Synthesis of -methyl)-undecane

[0665]

[0666] Example 9a: Compound 27, 2,2-di-pent-4-enyl-malonic acid diethyl ester

[0667] In a 100 mL round bottom flask, NaH (2.4 g, 0.1 mol, 60% (w / w) dispersion in mineral oil) was suspended in 50 mL dry DMF at 0°C under nitrogen. Dimethyl malonate 22 (2.3 mL, 0.02 mmol) was added to the mixture at 0°C, followed by 1-bromo-4-pentene (6.2 mL, 0.1 mmol). The suspension was stirred at room temperature for 2 hours, then gradually heated to 50°C and stirred overnight.

[0668] The next day, the reaction was cooled to room temperature and quenched with NH4Cl (50 mL, sat. aq.). The reaction mixture was extracted three times with ether (100 mL). The organic phases were combined, dried over MgSO4, filtered, and the solvent was removed under vacuum. The resulting residue was flash chromatographed to obtain the desired product 27 (4.0 g, 56% yield).

[0669] 1 H NMR (400MHz, CDCl3) δ: 5.78 (m, 2H), 4.99 (m, 4H), 3.72 (s, 6H), 2.06 (m, J = 7.50Hz, 4H), 1.89 (m, 4H), 1.26 (m, J = 7.50Hz, 4H).

[0670] Example 9b: Compound 28, 2,2-di(pent-4-enyl)-propane-1,3-diol

[0671] At 0 ° C, a solution of compound 27 (3.59 g, 0.015 mmol) from Example 9a in THF (15 mL) was added dropwise to a suspension of LiAlH4 in THF (30 mL), keeping an exothermic temperature below 5 ° C during the addition. The reaction was stirred overnight and monitored by TLC until complete conversion. The reaction was quenched by adding H2O (4 mL) and then 15% (w / v) NaOH (4 mL), and a white precipitate was observed. The suspension was filtered through two GF / A filters, and the filter cake was washed twice with 20 mL of THF. The suspension was transferred to a separatory funnel and extracted three times with DCM (50 mL). The combined organic phase was washed with brine (150 mL), dried over MgSO4, filtered, and the solvent was removed under vacuum. The resulting residue was flash chromatographed (heptane: EtOAc = 9: 1) to obtain the desired product 28 (2.0 g, 70% yield).

[0672] 1 H NMR (400MHz, CDCl3) δ: 5.80 (m, 2H), 4.98 (d, 4H), 3.57 (s, 4H), 2.04 (m, 4H), 1.30 (m, 8H).

[0673] Example 9c: Compound 29, 6,6-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-undec-1,10-diene

[0674] Compound 28 from Example 9b (1 g, 3.75 mmol) was dissolved in anhydrous toluene (80 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (176 mg, 7 mmol, 95% (w / w) in mineral oil, 7 equiv.) was added in portions. The mixture was then stirred at room temperature for 30 min, and m-PEG was added under N2 at 0°C. 45-OTs (13.2 g, 6.08 mmol, 6 equivalents) in toluene (100 mL) was azeotropically dried. The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC, and after completion the temperature was lowered to 15 ° C and the reaction was quenched by slowly adding H2O (20 mL). The solvent was evaporated and the residue was purified by flash chromatography (C18 column, H2O: acetonitrile = 60: 40) to obtain the desired product 29 (2.0 g, 70% yield).

[0675] 1 H NMR (500MHz, CDCl3) δ: 5.78 (m, J=16.9Hz, 2H), 4.94 (m, 4H), 3.69-3.60 (s, 391H), 3.53 (m, 4H), 3.37 (s, 6H), 1.99 (m, 4H), 1.25 (m, 8H).

[0676] Example 9d: Compound 30, 1,11-bis(triethoxysilyl)-6,6-bis(ω-methyl-(ethyleneoxy) 45 - Methyl)-Undecane

[0677] Triethoxysilane (1.47, 7.9 mmol, 40 equiv) was added to an azeotropically dried solution of compound 29 from Example 9c (0.91 g, 0.216 mmol) in toluene (7 mL). The reaction temperature was set to 30° C. and Karstedt's catalyst (32 μL, 2% (w / w) in xylene) was added. The reaction mixture was stirred at room temperature overnight.

[0678] pass 1 H-NMR monitoring reaction olefin proton disappearance. Subsequently evaporate the solvent, with anhydrous toluene (4mL) coevaporation to remove excess triethoxysilane. The product is dissolved in toluene (6mL), degassed with 3 vacuum / nitrogen cycles, and stirred at 60°C for 4 days with activated SIR-200 resin (300mg). After filtering and washing three times with toluene (10mL), evaporate the solvent and obtain compound 30 (85.3% purity (HPLC-ELSD)) in the form of a colorless solid.

[0679] Example 10: Synthesis of Compound 43, 1,5-bis(triethoxysilyl)-3,3-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-pentane

[0680]

[0681] Example 10a: Compound 32, 2,2-divinyl-propane-1,3-diol

[0682] At 0°C, a solution of compound 31 (214 mg, 1.01 mmol) in THF (2 mL) was added dropwise to a suspension of LiAlH in THF (5 mL), keeping the exotherm below 5°C during the addition. The reaction was stirred at room temperature overnight and monitored by TLC until complete conversion. The reaction was quenched by adding H2O (1 mL) followed by 15% (w / v) NaOH (250 μL). The suspension was filtered and the filter cake was washed with THF (25 mL). The suspension was transferred to a separatory funnel and extracted three times with DCM (2 mL). The combined organic phases were washed with brine (5 mL), dried over MgSO4, filtered, and the solvent was removed under vacuum to give the desired product 32 in quantitative yield.

[0683] 1 H NMR (400MHz, CDCl3) δ: 5.79 (m, 2H), 5.32 (d, J = 11.0 Hz, 2H), 5.22 (d, J = 17.6, Hz, 3H), 3.75 (s, 4H).

[0684] Example 10b: Compound 33, 3,3-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-penta-1,4-diene

[0685] Divinyl propanediol 32 from Example 10a (152 mg, 1.2 mmol) was dissolved in anhydrous toluene (6 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (149 mg, 5.9 mmol, 95% (w / w) in mineral oil, 5 eq) was added in three portions, keeping the temperature below 10°C. The slurry was stirred at room temperature for 60 minutes and then added to the m-PEG 400 solution under N2 at 0°C. 45 -OTs (10.78 g, 4.9 mmol, 4.2 equiv) in an azeotropically dried solution of anhydrous toluene (48 mL). The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC and after completion the temperature was lowered to 15 °C and the reaction was quenched by dropwise addition of H2O (3 mL). The solvent was evaporated and the residue was dissolved in DCM (20 mL). MgSO4 was added and the suspension was stirred for 20 minutes. The volatiles were evaporated under vacuum and the remaining MgSO4 was filtered off to give the desired product 33 in quantitative yield as a colorless solid.

[0686] Example 10c (prophetic example): Compound 34, 1,5-bis(triethoxysilyl)-3,3-bis(ω-methyl- (ethyleneoxy) 45 -methyl)-pentane

[0687] Before starting the reaction, water is removed from the starting material using a Dean-Stark apparatus. The two vinyl groups of compound 33 are hydrosilylated using a silane such as (EtO)3SiH and a catalyst such as a platinum compound such as Karstedt's catalyst. Optionally, any residual platinum is removed by treatment with activated SIR-200 resin to obtain final compound 34.

[0688] Example 11: Synthesis of Compound 37, 1,6-bis(triethoxysilyl)-3,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-hexane

[0689]

[0690] Example 11a: Compound 36, 3,4-bis(ω-methyl-(ethyleneoxy) 45 )-Hexa-1,5-diene

[0691] Divinyl glycol 35 (15 mg, 1.3 mmol) was dissolved in anhydrous toluene (20 mL) and cooled in an ice bath. When the internal temperature reached below 10°C, NaH (232 mg, 9.2 mmol, 95% (w / w) in mineral oil, 7 equiv) was added in three portions, keeping the temperature below 10°C. The slurry was stirred at room temperature for 60 minutes and then added to the m-PEG 400 solution under N2 at 0°C. 45 -OTs (8.28 g, 3.8 mmol, 3.2 equiv) in an azeotropically dried solution of anhydrous toluene (25 mL). The reaction mixture was heated to reflux overnight and stirred under N2. The reaction was monitored by HPLC and after completion the temperature was lowered to 15 °C and the reaction was quenched by dropwise addition of H2O (3 mL). The solvent was evaporated and the residue was dissolved in DCM (20 mL). MgSO4 was added and the suspension was stirred for 20 minutes. The volatiles were evaporated under vacuum and the remaining MgSO4 was filtered off to give the desired product 36 in quantitative yield as a colorless solid.

[0692] Example 11b (prophetic example): Compound 37, 1,6-bis(triethoxysilyl)-3,4-bis(ω-methyl- (ethyleneoxy) 45 )-Hexane

[0693] Before starting the reaction, water is removed from the starting material using a Dean-Stark apparatus. The two vinyl groups of compound 36 are hydrosilylated using a silane such as (EtO)3SiH and a catalyst such as a platinum compound such as Karstedt's catalyst. Any residual platinum is removed by treatment with activated SIR-200 resin to obtain final compound 37.

[0694] Example 12 (Prophetic Example): Synthesis of Compound 43

[0695]

[0696] Compound 43 was synthesized by first activating the alcohol group in 38 to form mesylate 39; then subjecting it to a nucleophilic substitution reaction with dimethyl malonate to afford compound 40; reducing the two ester groups with a reducing agent such as LiAlH4 to afford diol 41; deprotonating the two alcohol groups with a strong base such as NaH and reacting with a pegylation reagent such as m-PEG carrying a suitable leaving group; and 45 -OTs) coupling to obtain compound 42; finally, the two allyl groups are hydrosilylated using (EtO)3SiH and a catalyst (such as Karstedt's catalyst) to obtain compound 43.

[0697] Example 13 (Prophetic Example): Synthesis of Compound 49

[0698]

[0699] Compound 49 was synthesized by first activating the alcohol group in 44 to form mesylate 45; then subjecting it to a nucleophilic substitution reaction with dimethyl malonate to afford compound 46; reducing the two ester groups with a reducing agent such as LiAlH4 to afford diol 47; deprotonating the two alcohol groups with a strong base such as NaH and reacting with a pegylation reagent such as m-PEG carrying a suitable leaving group; and 45 -OTs) coupling to obtain compound 48; finally, the two allyl groups are hydrosilylated using (EtO)3SiH and a catalyst (such as Karstedt's catalyst) to obtain compound 49.

[0700] Example 14: Use of the compound according to the present application as a coating precursor

[0701] Compounds 10, 5, 12 and 14 were used as coating precursors for coating nanostructures.

[0702] Example 14a: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptyl Alkane, compound 10, use as coating precursor

[0703] The precursor nanostructure was synthesized by refluxing 93.60 g of 1,7-bis-(triethoxysilyl)-4,4-bis-(dimethylphosphonate)-heptane, 52 in 4501 g of 90.0% (v / v) aqueous ethylene glycol for 48 hours to obtain a precursor nanostructure solution with a hydrodynamic diameter of 17.6 nm and a phosphorus concentration of 69 mM.

[0704] Primed precursor nanostructures were synthesized by heating 4338 g of a solution of the precursor nanostructures with 116.48 g of bis(triethoxysilyl)methane at 100° C. for 4 hours, resulting in a solution of the primed nanostructures having a hydrodynamic diameter of 19.7 nm and a phosphorus concentration of 64 mM.

[0705] A 10-L jacketed reactor equipped with a mechanical stirrer, a temperature probe, an addition funnel heated to 40°C by a heating fan, and a reflux condenser connected to a N2 / vacuum manifold on top was charged with 6330 g of 90% (v / v) aqueous ethylene glycol and 3902 g of the prepared precursor nanostructure solution.

[0706] The jacket temperature was set to 125°C for 1 hour and then decreased to 110°C. While heating to 40°C, 548.2 g of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane was dissolved in 548.2 g of anhydrous ethanol to prepare a coating solution. When the internal temperature in the reactor reached 105°C, 250 mL of the coating solution was added. The remaining coating solution was slowly added at 50 mL / hour through the addition funnel. The jacket temperature was maintained at 110°C until 48 hours after the initial addition of the coating solution to the reactor, and then cooled to 20°C.

[0707] The reaction mixture was transferred to a 20-liter tank equipped with a 4-port cap. The reactor was rinsed with ultrapure water (5+4 liters) and the rinse was added to the tank. The tank was shaken to mix the contents. The contents were filtered into a fresh 20-liter tank through an autoclave filter assembly consisting of 1 μm, 0.4 μm, and 0.2 μm filters connected in series. The mixture was filtered using a 5400 cm 2 The filtered solution was purified by ultrafiltration through a 300kDTFF filter until the ethylene glycol concentration was less than 500 ppm.

[0708] Nanostructures synthesized in this way did not aggregate when exposed to 20 mM CaCl2.

[0709] Average diameter (DLS) = 26.7 nm, [P](ICP-OES)=60mM, [Si](ICP-OES)=220mM.

[0710] Example 14b: 4-[ω-methyl-(ethyleneoxy) 45 -methyl]-1,7-bis(triethoxysilyl)heptane, Use of the compound 5 as a coating precursor

[0711] By dissolving 1056 mg of 4-[ω-methyl-(vinyloxy) 45-methyl]-1,7-bis(triethoxysilyl)heptane in an equal mass of anhydrous dioxane to prepare the coating solution. A two-necked pear-shaped flask equipped with a reflux condenser connected to a N2 / vacuum manifold on the top was charged with 5 mL of a prepared nanostructure solution having a hydrodynamic diameter of 20.1 nm and a phosphorus concentration of 150 mM (the preparation of the solution was similar to that used in Example 14a) and heated in an oil bath at 110°C for 10 minutes. 200 μL of the coating solution was added to the nanostructure solution. An additional 1700 μL of the coating solution was added over 20 hours via a syringe pump, and the syringe and needle were heated to about 40°C by a heating fan. The reaction temperature was maintained at 110°C until 48 hours after the initial addition of the coating solution, and then cooled to room temperature. The solution was filtered through a 0.2 μm PES filter, diluted with water and filtered using a 115 cm 2 Purification was performed by ultrafiltration through a 300 kD TFF filter.

[0712] Nanostructures synthesized in this way did not aggregate when exposed to 20 mM CaCl2.

[0713] Average diameter (DLS) = 29.4 nm, [P](ICP-OES)=59mM, [Si](ICP-OES)=263mM.

[0714] Example 14c: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 67 -methyl)-heptyl Alkane, use of compound 12 as a coating precursor

[0715] A 13.4 mL sample of the prepared solution of nanostructures with a hydrodynamic diameter of 19.2 nm and a phosphorus concentration of 64 mM prepared in a manner similar to Example 14a was diluted to 36.1 mL with 90% (v / v) aqueous ethylene glycol in a two-necked round-bottom flask, the vertical neck of which was equipped with a reflux condenser connected to a N2 / vacuum manifold on top and the side necks were plugged with septa. The solution was heated in a preheated 110°C oil bath for 20 minutes, and then 1500 μL of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy))-1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy ... 67 A 50% (w / w) solution of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy))-1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy ... 67 After a total of 48 hours, the solution was cooled to room temperature.

[0716] The resulting nanostructured solution was diluted with water to 150 mL and filtered through a double-layer glass fiber filter, followed by filtration through a 0.2 μm polyethersulfone (PES) syringe filter. The resulting solution was diluted with water to 800 mL and concentrated to about 20 mL using a tangential flow filtration device with a nominal cutoff of 70 kD. The dilution-concentration process was repeated a total of 4 times, and then the solution was further concentrated to 20 mL on a rotary filter with a nominal cutoff of 300 kD.

[0717] Nanostructures synthesized in this way did not aggregate when exposed to 20 mM CaCl2.

[0718] Average diameter (DLS) = 32.5 nm, [P](ICP-OES)=45mM, [Si](ICP-OES)=233mM.

[0719] Example 14d: 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 90 -methyl)-heptyl Alkane, use of compound 14 as a coating precursor

[0720] A 4.1 mL sample of a solution of prepared nanostructures having a hydrodynamic diameter of 19.2 nm and a phosphorus concentration of 64 mM prepared in a manner similar to Example 14a was diluted to 11 mL with 90% (v / v) aqueous ethylene glycol in a two-necked round-bottom flask, the vertical neck of which was equipped with a reflux condenser connected to a N2 / vacuum manifold on top and the side necks were plugged with septa. The solution was heated in a preheated 110°C oil bath for 15 minutes, and then 530 μL of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy)- ... 91 A 50% (w / w) solution of 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy))-1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy ... 90 After a total of 48 hours, the solution was cooled to room temperature.

[0721] The resulting nanostructured solution was diluted with water to 40 mL and filtered through a double-layer glass fiber filter, followed by filtration through a 0.2 μm polyethersulfone (PES) syringe filter. The resulting solution was diluted with water to 800 mL and concentrated to about 20 mL using a tangential flow filtration device with a nominal cutoff of 70 kD. The dilution-concentration process was repeated a total of 4 times, and the solution was further concentrated to 10 mL on a rotary filter with a nominal cutoff of 300 kD.

[0722] Nanostructures synthesized in this way did not aggregate when exposed to 20 mM CaCl2.

[0723] Average diameter (DLS) = 41.2 nm, [P](ICP-OES)=24mM, [Si](ICP-OES)=116mM.

[0724] Example 15: Use of compounds outside the scope of the present application as coating precursors (reference examples)

[0725] Compounds 51 and 52 are compounds outside the scope of the present application and are used as reference examples.

[0726] Example 15a: 1-(ω-methyl-(ethyleneoxy) 45 -methyl)-3,5-bis(3-(triethoxysilyl)propoxy 1-(2-(4-(2-yl)-benzene)-compound 51 as a coating precursor (reference example)

[0727] At 40°C, 2500 mg of 1-(ω-methyl-(ethyleneoxy) 45 -methyl)-3,5-bis(3-(triethoxysilyl)propoxy)-phenylheptane, 51, was dissolved in an equal mass of anhydrous dioxane to prepare a coating solution. A two-necked pear-shaped flask equipped with a reflux condenser connected to a N2 / vacuum manifold on the top was charged with 8 mL of a prepared nanostructure solution having a hydrodynamic diameter of 15.1 nm and a phosphorus concentration of 99 mM (the preparation of the solution was similar to that used in Example 14a) and heated in an oil bath at 110°C for 5 minutes. 300 μL of the coating solution was added to the nanostructure solution. An additional 1970 μL of the coating solution was added over 20 hours via a syringe pump, and the syringe and needle were heated to about 40°C by a heating fan. The reaction temperature was maintained at 110°C until 48 hours after the initial addition of the coating solution and then cooled to room temperature. The solution was filtered through a 0.2 μm PES filter, diluted with water and filtered using a 115 cm 2 Purification was performed by ultrafiltration through a 300 kD TFF filter.

[0728] Average diameter (DLS) = 29.4 nm, [P](ICP-OES)=59mM, [Si](ICP-OES)=387mM.

[0729] Example 15b: 1-(ω-methyl-(ethyleneoxy) 45 )-10-triethoxysilyl-decane compound 52, as Use of coating precursor (reference example)

[0730] At 40°C, 425 mg of 1-(ω-methyl-(vinyloxy) 45)-10-triethoxysilyl-decane, 52, was dissolved in an equal mass of anhydrous dioxane to prepare a coating solution. 2.5 mL of a prepared nanostructure solution with a hydrodynamic diameter of 18.4 nm and a phosphorus concentration of 104 mM (the preparation of this solution is similar to the solution used in Example 14a) was charged to a reaction vial and heated in an oil bath at 110°C. 70 μL of the coating solution was added to the nanostructure solution. An additional 700 μL of the coating solution was added over 20 hours via a syringe pump, and the syringe and needle were heated to about 40°C by a heating fan. The reaction temperature was maintained at 110°C until 94 hours after the initial addition of the coating solution, when it was cooled to room temperature. The solution was filtered through a 0.2 μm PES filter, diluted with water and filtered using a 115 cm 2 Purification was performed by ultrafiltration through a 300 kD TFF filter.

[0731] Average diameter (DLS) = 25.3 nm, [P](ICP-OES)=35mM, [Si](ICP-OES)=150mM.

[0732] Example 16: Comparison between coated nanostructures coated with a coating precursor according to the present application and nanostructures coated with a reference coating precursor outside the scope of the present application

[0733] Nanostructures coated with compounds 5 and 10 were compared to nanostructures coated with a compound outside the scope of this application (compound 51).

[0734] Example 16a: Nanostructures coated with a precursor according to the present application have a higher Structure longer plasma half-life.

[0735] The coated films prepared according to Examples 14a, 14b and 15a were 1,7-bis(triethoxysilyl)-4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-heptane (Compound 10) (Test Item A), coated with 4-[ω-methyl-(ethyleneoxy) 45 -methyl]-1,7-bis(triethoxysilyl)heptane (Compound 5) (Test Item B), and nanostructures coated with the reference compound 1-(ω-methyl-(ethyleneoxy) 45-methyl)-3,5-bis(3-(triethoxysilyl)propoxy)-benzene (Compound 51) (Test Item C, reference compound, outside the scope of this application), loaded with yttrium in the form of YCl3 so that [P] / [Y] is 23 (± 1). The test items for injection were prepared by adjusting [Ca], pH and osmotic pressure to physiological levels with CaCl2, NaOH and mannitol, respectively. In vivo behavior was studied by injecting the test items into female BALB / c mice at a dose of 2 μmol Y / kg. Blood was sampled 1, 6 and 24 hours after injection, and [Y] and [Si] in plasma were analyzed by ICP-OES. The results in the form of circulation half-life are shown in Table 1.

[0736] Table 1. Plasma half-life of coated nanostructures coated with coating precursors according to the present application (A and B) and a reference coating precursor (C), calculated from [Y] and [Si] measured by ICP-OES.

[0737] Test items <![CDATA[t 1 / 2 (Y)(h)]]> <![CDATA[t 1 / 2 (Si)(h)]]> A 9.4 4.5 B 7.3 4 C(reference) 3.5 2.1

[0738] As can be seen in Table 1, the nanostructures (A) and (B) coated with the coating precursor according to the present application show significantly extended cycle times compared to the nanostructures coated with the reference coating precursor (C).

[0739] Example 16b: Nanostructures coated with a precursor according to the present application have a higher Better storage stability of the structure

[0740] The nanostructures coated with compound 51, ie the coated nanostructures according to Example 15a, were stored for 48 hours at 4° C. By SEC-ELSD measurement, decomposition products associated with coating detachment were detected in total concentrations of >5% (area / area).

[0741] The nanostructures coated with compound 10, i.e. the coated nanostructures according to Example 14a, were stored at 4°C for 106 days. By SEC-ELSD measurement, decomposition products associated with coating shedding were detected at a total concentration of <3% (area / area). This indicates that the storage stability of the nanostructures coated with the coating precursor of the present application is increased by about 2 orders of magnitude compared to the nanostructures coated with the reference coating precursor.

[0742] The nanostructures coated with compound 10, i.e. the coated nanostructures according to Example 14a, were stored at 4°C for 76 days. DLS was measured before (27.0 nm) and after (26.9 nm) storage, and no significant changes in the diameter of the nanostructures were detected. This indicates that the nanostructures coated with the coating precursor of the present application have good storage stability in terms of aggregation.

[0743] Example 17: Use of a nanostructure coated with a coating precursor according to the present application in a pharmaceutical composition

[0744] 4T1 cells (1×10 5 Tumors were induced in 10-week-old female BALB / c mice.

[0745] The coated nanostructures according to Example 14a (nanostructures coated with compound 10) were loaded 177 Lu to a concentration of approximately one atom per nanostructure 177 Lu and prepared for injection by adding Tris buffer, CaCl2 and normal saline (150 mm NaCl).

[0746] When the tumor volume reaches 200-300mm 3 On the 14th or 15th day after inoculation, the treated group (n=16) was injected with 218MBq / kg of 177 The antitumor efficacy was monitored by following tumor growth and overall survival.

[0747] Compared with the control group, the treatment group showed significantly increased mean and median survival time (see Table 2). In addition, tumor growth in the treatment group was significantly slowed down (see Fig.12 ).

[0748] Table 2. Loading 177 Median and mean survival times of Lu-coated nanostructures and control-treated female BALB / c mice bearing 4T1 tumors.

[0749]

[0750] Therefore, the nanostructure coated with the coating precursor according to the present application can be used in a pharmaceutical composition. The pharmaceutical composition can be used to treat cancer.

[0751] Furthermore, it has been demonstrated that nanostructures coated with a coating precursor according to the present application can be used as carriers of radionuclides.

[0752] Example 18: Use of the nanostructure coated with the coating precursor according to the present application as a carrier of radionuclides

[0753] As in Example 17, 177 Lu loading of the coated nanostructures according to Example 14a (nanostructures coated with compound 10). No unbound 177 Lu. Less than 2.5% on radio-TLC on silica eluted with citrate buffer1 of 77 Lu is mobile, and the remaining part is bound to the nanostructure, which is completely retained at the baseline of the TLC plate.

[0754] This indicates that the nanostructure coated with the coating precursor according to the present application can be used as a carrier of radionuclides.

[0755] Example 19: 4,4-bis(ω-methyl-(ethyleneoxy) 45 -methyl)-hept-1,6-diene, hydrosilylation of compound 9 under standard hydrosilylation conditions, indicating the superiority of the hydrosilylation method of the present application (reference examples outside the scope of the present application)

[0756] A 10 mL round bottom flask was charged with 600 mg of azeotropically dried compound 9 (0.15 mmol), 5 mL of toluene and 100 mg of freshly distilled triethoxysilane (0.6 mmol, 4 eq.). The solution was degassed and heated to 30°C, and then 11 μL of Karstedt catalyst solution (2% (w / w) Pt, 1.1 μmol, 0.07 eq.) was added. Heating to 40°C overnight gave a reaction mixture containing only 6% (a / a) of compound 10 and 73% (area / area) of a byproduct containing only one silane moiety.

[0757] It is noteworthy that the synthesis of compound 10 by the method of the present application resulted in a purity of compound 10 exceeding 90%, as shown in Example 3. Therefore, the method of the present application is superior to the standard method for hydrosilylation.

[0758] Example 20 (Prophetic Example): Recalibration of the salt concentration used for the extraction and purification of the di-PEGylated diene of formula (II) to use a salt other than NaCl

[0759] Interpolation extracted by representative tests, for salt M x A y The concentration was recalibrated for the NaCl concentration used for the extraction and purification of the di-PEGylated diene.

[0760] A mixture comprising a di-pegylated diene according to formula (II) and at least two impurities which are usually present in a reaction mixture when the di-pegylated diene is synthesized by pegylation of a diene according to formula (III) is dissolved in water to a concentration similar to that used in a process for extractive purification of the di-pegylated diene. The solution is divided into 8 portions, A to H.

[0761] Part A was treated with sodium chloride to a concentration of [NaCl] i, similar to the method used for the intermediate extraction step in the extraction purification process of the di-PEGylated diene.

[0762] Part B, Part C and Part D are marked with M x A y Treated to concentration [M x A y ] B 、[M x A y ] C , and [M x A y ] D For [M x A y ] ref-i 0.75, 1 and 1.25 times of x A y ] ref-i It is M x A y The concentration that will give the solution the same ionic strength as a solution of NaCl in pure water is [NaCl] i , assuming that B, C, and D contain pure water.

[0763] Part E was treated with sodium chloride to a concentration of [NaCl] p , similar to the method used for the product extraction step in the extractive purification method of the di-PEGylated diene.

[0764] M for parts F, G, and H x A y Treated to concentration [M x A y ] F 、[M x A y ] G , and [M x A y ] H For [M x A y ] ref-p 0.75, 1 and 1.25 times of x A y ] ref-p It is M x A y The concentration that will give the solution the same ionic strength as a solution of NaCl in pure water is [NaCl] p , assuming that F, G and H contain pure water.

[0765] Parts A to H are each extracted once with a primary extraction solvent at a temperature above 50°C to produce an aqueous phase A. 水性 -H 水性 and organic phase A 有机 -H 有机 .

[0766] Use appropriate analytical methods (e.g. HPLC) to assess the 水性 -H 水性 and A 有机 -H 有机 relative composition.

[0767] For each fraction, calculate Q i and each impurity present, I j Ratio

[0768]

[0769] For each impurity, plot r(B 有机 , I j )、r(C 有机 , I j ), and r(D 有机 , I j ) as [M x A y ] and use linear regression to find [M x A y ] so that r is equal to r(A 有机 , I j ). In this way, all impurities [M x A y ], calculated as -[M x A 和 ] 平均-中间-有机 .

[0770] [M x A y ] 平均-中间-水性 Calculated in a similar manner, and [M x A y ] 平均-中间 Calculated as [M x A y ] 平均-中间-有机 and [M x A y ] 平均-中间-水性 Similarly, fractions D to H were used to calculate [M x A y ] 平均-产物 . Use point {[NaCl] i :[M x A y ]平均 -middle} and {[NaCl] p :[M x A y ] 平均-产物}A linear model was fitted and used to recalibrate the concentration of NaCl to M x A y concentration.

[0771] Example 21: Concentration of a solution of coated nanostructures, demonstrating the high solubility of nanostructures coated with a coating precursor according to the present application in water

[0772] A 20 mL sample of the nanostructures according to Example 14a (nanostructures coated with compound 10) was concentrated on a 300 kDa spin filter. The concentration of P was measured by ICP-OES to be 328 mM, corresponding to approximately 25% (w / v) of nanostructures in solution. The hydrodynamic diameter was measured to be 27.4 nm, and no aggregates were observed by visual inspection, indicating no aggregation.

[0773] This demonstrates the high solubility and aggregation resistance of the nanostructures coated with the coating precursor according to the present application.

Claims

1. A compound according to formula (I): in, Poly 1 and Poly 2 independently selected from the group consisting of hydrogen and a hydrophilic polymer group with a molecular weight of 400Da to 10000Da; wherein Poly 1 or Poly 2 At least one of the groups is a hydrophilic polymer group having a molecular weight of 400Da to 10000Da; Y 1 and Y 2 is independently -A(CH2) n B-; among them A binds to X; Y 1 B in the binds to Poly 1 ; Y 2 B in the binds to Poly 2 ; n is an integer between 0 and 5; A is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond; and B is selected from the group consisting of -O-, -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)- and a covalent bond, provided that when Poly 1 or Poly 2 Zhong and Y 1 or Y 2 When the bonded atom is not a carbon atom, B is a covalent bond; Y 3 and Y 4 is independently -E(CH2) m -;in, E binds to X; m is an integer between 2 and 5; and E is independently selected from the group consisting of -S-, -NH-, -C(=O)O-, -C(=O)NH-, -O(C=O)-, -NH(C=O)-, and a covalent bond; and X is selected from the structure X 1 , X 2 , X 3 , X 4 and X 5 The group composed of in, Bold keys are bound to Y 1 or Y 2 Keys; Non-bold bonds are bound to Y 3 or Y 4 and p is an integer between 1 and 5; as well as Z 1 and Z 2 Independently -SiR 1 R 2 R 3 ,in, R 1 , R 2 and R 3 Independently selected from the group consisting of chlorine, bromine, iodine, lower alkoxy, aryloxy, carboxyl, amino and -NH-acyl.

2. The compound according to claim 1, wherein Poly 1 and Poly 2 It is a hydrophilic polymer group with a molecular weight of 400Da to 10000Da.

3. The compound according to claim 1 or 2, wherein n is an integer between 1 and 3, preferably n is 1 or 2, even more preferably n is 1.

4. A compound according to any one of the preceding claims, wherein In Y 1 and Y 2 , n is 1.

5. A compound according to any one of the preceding claims, wherein X is X 1 .

6. A compound according to any one of the preceding claims, wherein In Y 1 and Y 2 In the formula (A), A is a covalent bond, B is -O-, and n is an integer between 1 and 3.

7. A compound according to any one of the preceding claims, wherein In Y 3 and Y 4 In the equation, E is a covalent bond.

8. A compound according to any one of the preceding claims, wherein The hydrophilic polymer group comprises a PEG chain, optionally wherein the PEG chain is terminated by a lower alkyl group.

9. The compound according to claim 8, wherein Each hydrophilic polymer group includes 20 to 150 ethylene glycol residues.

10. A compound according to any one of the preceding claims, wherein Poly 1 and Poly 2 It is ω-methyl-(ethyleneoxy) w , where w is 20 to 150; In Y 1 and Y 2 In the formula (A), A is a covalent bond, B is -O-, and n is 1; Y 3 and Y 4 All are -CH2-CH2-CH2-; X is X 1 ;as well as Z 1 and Z 2 Independently selected from the group consisting of triethoxysilyl and trimethoxysilyl.

11. A compound according to formula (II): in, R 7 and R 8 independently selected from the group consisting of lower alkyl; p is an integer between 20 and 150; q is an integer between 20 and 150; r is an integer between 1 and 3; s is an integer between 1 and 3; t is an integer between 0 and 3; u is an integer between 0 and 3; as well as X chooses freedomX 1 , X 2 , X 3 , X 4 and X 5 The groups consist of: in Bold bonds indicate bonding to CH2] r and [CH2] s Keys; Bonds not in bold indicate bonds to [CH2] t and [CH2] u and p is an integer between 1 and 5.

12. Use of a compound according to claim 11 in the preparation of a compound according to any one of claims 8 to 10.

13. A method for purifying the compound according to claim 11, comprising the following steps: a) providing an aqueous solution of the impure compound according to claim 11, wherein the aqueous solution comprises: Water in an amount of 7.5 to 16.5 times the total mass of the impure compound according to claim 11; and NaCl in an amount of 6% to 9% (w / v) of the amount of said water; b) subjecting the aqueous solution of step a) to 2 to 5 intermediate extractions at a temperature between 40° C. and 70° C., wherein each intermediate extraction comprises the following steps: b1) optionally; adding an additional portion of NaCl such that the total amount of NaCl added corresponds to an amount of NaCl less than 9% (w / v) of the amount of water in the aqueous solution of step a); b2) extracting the aqueous solution with a carboxylate solvent; and b3) removing the organic phase to provide an aqueous phase; c) adding to the aqueous phase from step b3) an amount of NaCl in an amount of at least 1% of the amount of water in step a), such that the total amount of NaCl corresponds to an amount of NaCl between 8% and 12%, and subjecting the aqueous phase to 2 to 5 product extractions at a temperature between 40° C. and 70° C., wherein each product extraction comprises the following steps: c1) extracting the aqueous phase with a carboxylic acid ester solvent; and c2) removing the organic phase; d) combining the organic phases from each step c2); e) concentrating the combined organic phases from step d) to obtain a residue; f) dissolving the residue from step e) in an aqueous buffer having a pH between 6 and 9 to provide an aqueous phase; g) subjecting the aqueous phase from step f) to 2 to 4 refining extractions, wherein each refining extraction comprises the following steps: g1) extracting the aqueous phase from step f) with a chlorinated solvent; and g2) removing the organic phase; h) combining the organic phases from each step g2); and i) concentrating the combined organic phases from step h) to obtain a residue comprising a diPEGylated diene according to claim 11 having an impurity content of less than 10% (w / w).

14. A method for preparing a compound according to any one of claims 8 to 10, wherein Poly 1 and Poly 2 The method comprises the following steps: i) providing a diene according to claim 11, optionally purified by a process according to claim 13; ii) reacting the diene with at least 30 equivalents of the structure HSiR in the presence of a platinum catalyst and an aromatic solvent at a temperature between 10°C and 35°C 1 R 2 R 3 contacting with a hydrosilylation agent, wherein R 1 , R 2 and R 3 independently selected from the group consisting of lower alkoxy; iii) removing excess hydrosilylation agent; and iv) Removal of platinum from the product.

15. Use of a compound according to any one of claims 1 to 10 or claim 11, or a product of a process according to claim 12, 13 or 14 as an intermediate in the preparation of coated nanostructures.

16. A spherical nanostructure having a hydrodynamic diameter between 10 nm and 100 nm, wherein: The nanostructure has a coating derived from a compound according to any one of claims 1 to 10 or claim 11, or the product of a method according to claim 12, 13 or 14. The spherical nanostructure according to claim 16 , further comprising a radionuclide.

18. A pharmaceutical composition comprising a plurality of spherical nanostructures according to claim 16 or 17.

19. A pharmaceutical composition for treating cancer or for imaging, wherein: The pharmaceutical composition comprises a plurality of spherical nanostructures according to claim 17.

20. Use of the spherical nanostructure according to claim 16 as a radionuclide carrier.

Citation Information

Cited By

  • Synthesis method of 1, 4-cyclohexanedimethanol diglycidyl ether

    CN120817916A

  • A process for the preparation of 1,4-cyclohexanedimethanol diglycidyl ether

    CN120817916B